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ABSTRACT 
Development of a Cell-Depositing System Using Inkjet Technology 
Jason Robert Ozaeta 
 
In the past decade, advances in tissue engineering have allowed researchers to 
fabricate simple tissues.  However, the process of creating these native tissues is a time 
consuming and inefficient process.  A scaffold must first be fabricated then exposed to a 
sea of cells in the hopes of seeding.  Furthermore, even though cells may have attached, 
more time must be spent in order to allow the cells to migrate to their ideal locations.  To 
deal with this problem, researchers have investigated whether rapid prototyping 
principals could be adapted to facilitate the cell seeding process by placing cells in their 
respective locations during scaffold fabrication.  The goal for this thesis was to establish 
the foundation for a cell-compatible printer that, in the future, could fabricate pre-seeded 
scaffolds.  This task included implementing changes to a commercial solenoid-based 
inkjet system that would allow cells to be loaded into the printer in a sterile fashion.  In 
addition, protocols had to be designed with system limitations in mind.  An initial test 
with the designed system showed a majority of cell viability percentages above 90%.  If 
additional tests confirm this possibility, the system should be further modified to provide 
cells with a proper culturing environment.  Furthermore, additional research would need 
to be performed in order to determine whether scaffolding materials can be dispensed 
through the system to fabricate scaffolds. 
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1.0 INTRODUCTION 
 There is a growing concern in the medical field regarding tissue damage 
treatments, where a declining trend can be seen in tissue availability.  For example, the 
number of U.S. patients on the kidney transplant active waiting list is increasing.  In 
1996, the waiting list had about 29,000 patients; in 2006, there were over 45,000.  In 
contrast, the number of patients that actually received a transplant increased from about 
10,000 to only about 16,000 patients [61].  This widening gap in transplant supply-and-
demand demonstrates that organ transplant surgery is unable to meet the growing demand 
for tissue.  Furthermore, the few patients that are able to receive the vital organ transplant 
will most likely require immunosuppressant therapy for the rest of their lives to prevent 
tissue rejection.  Other options for tissue-replacement patients do not offer much 
potential, either.  Surgical reconstruction, for example, is affected by similar donor 
shortage problems, as well as the risk of donor site morbidity.  The third option, artificial 
organs and/or mechanical intervention, puts patients at risk for thrombosis and infection.  
Furthermore, mechanical devices currently have a limited lifespan [16].  With these 
limitations in mind, researchers looked for a new way to tackle the rising tissue shortage. 
In 1987, researchers established a new field of study to specifically tackle this 
tissue shortage.  Tissue engineering is defined as an interdisciplinary field that applies the 
principles of engineering and life sciences towards the development of biological 
substitutes that restore, maintain, or improve tissue function [69].  This field combines 
the efforts of cell biologists, engineers, material scientists, mathematicians, geneticists, 
and clinicians to fabricate new tissue that can mimic native tissue function [16].  
Furthermore, to serve as a better alternative than the previously mentioned clinical 
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treatments, these engineered tissues also need to elicit no major immunogenic responses.  
Tissue engineering potentially can offer doctors the ability to repair damaged tissue much 
more effectively than current clinical methods. 
 The current technique for engineering tissue, described in greater detail later in 
this paper, involves the use of pre-made scaffolds, which are 2D or 3D structures onto 
which cells can adhere to and develop on.  These scaffolds, which also facilitate nutrient 
transport and provide mechanical support for the cells, require a complex network of 
interconnecting pores for adequate nutrient diffusion throughout the structure [31].  This 
complex pore network, however, cannot easily be fabricated using traditional 
manufacturing techniques.  Furthermore, depending on the size of the scaffold, the cells 
cannot always diffuse through the entire scaffold to fully seed the construct.  These issues 
stress a need for a better method of tissue fabrication. 
Researchers began to investigate another recently developed technology to 
possibly resolve these issues.  Rapid prototyping (RP) evolved out of a need to visualize 
and test a product without sacrificing time.  The key to rapid prototyping is cheap, easily 
fused/bound material(s) and a layer-based assembly method.  For tissue engineers, 
however, the ability to build complex shapes layer-by-layer could allow for the creation 
of better scaffolds.  By creating an interconnected porous substructure, researchers 
believe that these scaffolds will allow for better tissue properties. 
However, while RP systems have been increasingly used for scaffold research, 
relatively few studies have been examined the possibility of RP-based cell seeding.  
Although RP devices can build a scaffold on-demand, most researchers still seed cells the 
“classical” way, following scaffold production.  If a scaffold can be built layer-by-layer 
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to generate complex patterns, why can’t the same system also strategically place cells for 
better migration and tissue function?  Since tissues rely on groups of cells that are not 
randomly distributed within its matrix, tissue-engineering techniques should be designed 
to best place the cells without relying too heavily on uniform cell distribution to achieve 
this goal.   
This thesis project was intended to create a proof-of-concept for a potential RP 
system that is capable of seeding cells onto specific locations.  An existing commercial 
ink-jet system was modified to accept a variety of fluids.  A closed-system fluid reservoir 
was developed to maximize sterility at the inlet, and a protocol was developed to 
maximize the system’s sterility prior to depositing cells.  If everything works as planned, 
this system should be able to dispense viable cells.  The long-term goal for this project is 
to develop a novel, low-cost RP system capable of constructing a 3D bioactive scaffold 
autonomously.  The multiple ink-jet heads should make it possible to dispense different 
materials simultaneously.  As a result, it should be possible, in the future, to integrate 
cells into a scaffold as the construct is being built.  While far from complete realization, 
achieving such a goal could lead to the solution for our growing tissue shortage. 
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2.0 TISSUE ENGINEERING FUNDAMENTALS 
 The field of tissue engineering requires a vast body of information.  This large 
knowledge base comes from the wide variety of disciplines involved in this research 
field.  Therefore, to understand this interdisciplinary field, one needs to understand the 
basics of some of these disciplines.  On the biological side, one should be familiar with 
the individual components in the body that allow for tissue formation: the extracellular 
matrix, cells, and other stimuli.  Because this field is still relatively young, new and 
different techniques are always being developed, and sometimes can be hard to follow.  
Therefore, one should also understand the basic fundamentals of the classical tissue 
engineering approach in order to understand the need for researching new techniques.  
 
2.1  What Are Tissues? 
 Tissues can be defined as a collection of similar cells that perform a common 
function.  In order to understand this definition, one should consider differences between 
unicellular and multi-cellular organisms.  A unicellular organism is the most basic of 
organisms, dedicated to performing a single function.  Multi-cellular organisms, as 
implied by its name, contain many cells.  If one assumes that different cells perform 
different functions, then a multi-cellular organism could potentially perform more 
complex functions.  In a competitive environment, these organisms need to maximize its 
survivability.  As a result, organization of the cells is required, as grouping similar cells 
or cells that work best together can optimize throughput.  These groupings ultimately lead 
to a separation of specialized cells, better known as a tissue. 
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 Tissues can be classified into four major categories: muscle, connective, nervous, 
and epithelial.  The primary function of all muscle tissue is to provide contractile force.  
In comparison to muscles, connective tissue provides little or no contractile force.  As its 
name implies, this form of tissue connects and provides support to various parts of the 
body.  Nervous tissue provides the body with a quick communication system.  This tissue 
is comprised of many neurons that synapse together to form a communication pathway.  
Epithelial tissue allows the body to maintain homeostasis, mainly by providing protective 
barriers and facilitating with water retention. 
 
2.2  The Extracellular Matrix 
 In tissue engineering, researchers must be able to recreate an environment ideal 
for supporting tissue growth.  Part of this ability involves replicating or simulating parts 
of tissues needed for cell attachment and other sustaining functions.  Looking at one of 
the individual tissue components, the extracellular matrix (ECM) is a three-dimensional 
network of macromolecules in which smaller molecules, such as proteins, ions, and 
water, are bound to [15].  This matrix provides both structure and support for the smaller 
molecules.  The ECM also provides a number of other functions, such as ion balance, 
intercellular communication, and cell migration/adhesion.  These various functions allow 
for the growth of cells into tissue.  This section will provide a brief describe several ECM 
components that have been utilized by other researchers for cell patterning. 
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2.2.1 Collagen 
 Collagen, which is the most abundant protein in the body, serves as an aggregate 
to form various macrostructures, such as fibrils, basement membranes, filaments, canals 
and sheets.  Currently, there are 27 known types of collagen and proteins with collagen-
like domains [15].  Of these 27 types, types I, II, and III are the most abundant forms of 
collagen found in the body.  Type I collagen is found mostly in connective tissue, such as 
the skin, tendons, and bone; type III collagen is usually found with type I collagen.  Type 
II collagen can be found in cartilage [26].  These types of collagen are usually 
synthesized by fibroblasts in precursor form, and then are processed once secreted into 
the ECM [23].  Because of its affinity for cell attachment, tissue engineers have used this 
component to provide specific attachment sites for cells used in their research.  Roth et 
al., for example, used collagen in a commercial printer and patterned collagen onto a 
glass coverslip [47].  This technique created a pattern of cell attachment sites surrounded 
by cell-repellant material, which would dictate where cells would attach. 
 
2.2.2 Fibronectin 
 Fibronectin, one of the first ECM proteins to be characterized, is important in 
attaching cells to the ECM.  This molecule is rod-like in structure and is comprised of 
three domain types that serially repeat [1].  Of the three repeatable domains, type III 
fibronectin repeat is the most common domain.  This domain contains a pep-tide 
sequence arginine-glycine-aspartic acid, also known as RGD, which has been shown to 
be an important feature of the domain’s binding site [1].  Utilizing this characteristic, 
Klebe et al. have investigated the possibility of printing fibronectin onto substrates for 
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patterned cell attachment [27].  Like research by Roth et al., Klebe et al’s research did not 
include printing cells directly, but rather demonstrated that printers could be used to 
influence and direct cell attachment by controlling where the cell attachment sites are. 
 
2.2.3 Laminin 
 As its name might imply, laminin is found in basal laminae, which are thin “mats” 
of ECM that underlie epithelial vessels and surround muscle and adipose tissue [1].  The 
basal laminae serve as a separation layer between the previously mentioned tissues and 
surrounding connective tissue.  Many cells use the laminin as a sub-stratum for cell 
migration [15].  Furthermore, laminin also is believed to promote neuronal growth.  
Because of these features, researchers, like Turcu et al., have used laminin to serve as cell 
adhesion sites, similar to research using collagen and fibronectin [57].  In their research, a 
custom dispensing system was created that allowed the researchers to create patterns of a 
laminin mixture on various substrates.  As expected, neuronal cells adhered mainly along 
the printed laminin pattern.  Their results, along with Klebe and Roth, show that printers 
have potential application for cell patterning. 
 
2.3  Cells 
 The other vital components for engineering a tissue are cells.  Living cells need to 
be obtained in order to proliferate and differentiate into the desired cells.  Once obtained, 
these cells are cultured repeatedly to increase its population to a useable size.  Because 
the cells are alive, a proper environment must be maintained to maximize their longevity.  
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Also, the cultured cells need to be occasionally assessed to ensure they are still usable. 
This section will briefly review various types of cells currently in use by tissue engineers. 
 
2.3.1 Autologous Cells 
 A number of cell types, categorized by their source, are used in tissue engineering 
applications.  Autologous cells are the most ideal cells to use for a few reasons.  These 
cells are obtained from the patient, usually through a biopsy.  As a result, autologous cells 
have the main advantage in eliminating any chance of an immunogenic reaction, since the 
cells would express the patient’s own native surface markers.  If the target tissue is 
present and healthy, the patients own cells would be especially advantageous during 
culturing.  Cells from target tissues often are already differentiated, so chemical 
stimulation with growth factors is not needed as much to induce desired tissue function.  
This cell type has been successfully applied in tissue reconstruction.  In research by Atala 
et al., cells were obtained via biopsy samples from the bladders of several patients with 
myelomeningocele [3].  Each individual’s cells were cultured, seeded onto a synthetic 
bladder scaffold (which will be discussed in the next section), and cultured.  The resulting 
constructs were then implanted in their respective patient.  Following surgery, most of the 
patients saw improved bladder and bowel functionality.  Furthermore, no significant 
immunogenic reactions or rejection took place.  Atala’s results demonstrated that 
autologous cells can produce tissue with proper physiologic function and little rejection 
or reaction. 
 While obtaining cells from the patient’s own target tissue would be an ideal 
condition for culturing the same tissue, this method has some disadvantages as well.  
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First, few cells are easily accessible for harvesting.  Elderly patients or patients with 
diseased tissue, for example, will most likely yield few, if any, healthy cells [21].  
Furthermore, the cells may not be available at all if the target tissue was removed prior to 
its need.  Because these cells are obtained from target tissue, they are severely limited in 
the types of tissue it can differentiate into.  Due to these restrictions, other sources of 
autologous cells have been researched for tissue engineering. 
 
2.3.2 Stem Cells 
 Recently, stem cells have been used to generate larger quantities of tissue.  Two 
types of stem cells are currently used in research.  Embryonic stem cells are, as its name 
implies, obtained from embryos.  Adult stem cells, on the other hand, are obtained from 
various locations on an adult’s body.  Unlike differentiated cells, stem cells are able to 
differentiate into a number of cells.  However, the difficulty in achieving this variation 
depends on the type of stem cell. 
 Recently, five cell lines, derived from blastocytes in human embryos, were shown 
to be pluripotent; in other words, they were shown to be able to differentiate into virtually 
any cell type [21].  These embryonic stem cells (ESCs) were believed to exhibit 
unlimited self-renewal.  As a result, it could have been possible to culture almost any 
tissue with this single cell line.  However, the controversial use of this cell type made it 
difficult to acquire funding; human embryonic stem cell research could not qualify for 
National Institute of Health funding unless cells were obtained from embryos before 
August 9, 2001 [62].  So while this cell type offered significant advantages, ethical issues 
limited its use in research. 
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As an alternative to ESCs, adult stem cells (ASCs) offer similar advantages but 
without the controversy.  Unlike ESCs, adult stem cells are not obtained from embryos, 
but rather in tissues of living animals.  For example, the most “common” adult stem cell, 
mesenchymal stem cells (MSCs), could be obtained in multiple tissues, such as muscle, 
cartilage, bone marrow, liver, and pancreas [21].  Despite the many locations, these cells 
are incredibly rare within the body.  Often, researchers are unable to obtain sufficient 
numbers of ASCs needed for transplantation and cultivation.  However, these rare cells 
offer great potential.  These cells are believed to exist in tissues in order to maintain 
homeostasis.  The cells become activated when tissue damage occurs.  Like ESCs, ASCs 
are also capable of self-renewal for the lifetime of the organism.  More importantly, 
ASCs are undifferentiated.  Because of this trait, ASCs could be induced to differentiate 
into a wide variety of cells.  While was is difficult to prove that these cells were 
pluripotent, many studies did support the belief that ASCs were at least multipotent.  In 
one study, for example, hematopoietic stem cells from one mouse were shown to 
completely regenerate lethally irradiated hematopoietic systems of other mice [62].  This 
amazing feat demonstrated the enormous potential that ASCs had for tissue engineers. 
 
2.3.3 Progenitor Cells 
Progenitor cells are technically intermediates of the stem cell, but have 
significantly different characteristics.  While stem cells are undifferentiated, progenitor 
cells are “committed” towards differentiating along a certain pathway; in other words, 
these cells are partially differentiated.  When stem cells divide, at least one identical cell 
is created, hence the self-renewing characteristic.  On the other hand, when progenitor 
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cells divide, both resulting cells are further differentiated.  As a result, these cells 
eventually result in a fully differentiated cell.  However, since these cells initially have 
different development pathways, progenitor cells are considered multipotent.  For 
example, researchers have used mesenchymal progenitor cells to grow muscle, bone [69, 
37], cartilage [66], tendon [28], and vascular tissue.  While these cells have the ability to 
differentiate into many cell types, a lot of work involving biological, physical, and 
chemical stimuli is required.  Furthermore, like adult stem cells, progenitor cells are fairly 
rare in the body.  It is also difficult to distinguish between ASCs and progenitor cells, 
though progenitor cells could be isolated using markers specific to certain cell 
phenotypes. 
 
2.4 Natural Scaffold Materials 
Researchers are using the knowledge gained about the ECM to develop 
techniques for synthetically engineering tissue.  Currently, tissue engineers utilize a pre-
built, engineered scaffold, which is a three-dimensional structure that serves as a support 
matrix for cells to restore, maintain, or improve tissue [70].  Both natural, ECM-based 
and synthetic, polymeric materials are used to create these structures.  One of the ways 
the scaffold supports the cells is by providing an adherent surface for the cells to 
proliferate and differentiate.  In addition to an adherent surface, scaffolds may also 
provide mechanical support to the cells.  Furthermore, scaffolds must also allow for 
nutrient and waste transport to sustain cells that migrate.  Because these constructs are 
eventually going to be implanted, researchers have to account for any immunogenic 
reactions that a foreign material could induce.  Although this project is dedicated to cell 
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deposition, scaffolds will still be used by this system.  Researchers are also investigating 
the possibility of fabricating complex scaffolds using rapid prototyping techniques, which 
will be explained in a later chapter.  Because a future goal for this system will be the 
ability to fabricate a scaffold and simultaneously seed cells during fabrication, the 
following two sections will briefly discuss scaffold materials that could be used in such a 
system. 
 
2.4.1 ECM-based Polymer Scaffolds 
Since the goal of the scaffold is to emulate parts of the ECM, natural ECM 
components could be used as scaffold materials.  For example, scaffolds have been 
coated with hyaluronic acid to improve the scaffold’s cell-adhesion [30].  Although the 
primary structure of this scaffold was fabricated using a synthetic polymer, the use of this 
ECM component demonstrated that such a material could be integrated to add specific 
characteristics.  ECM components do not have to be relegated to just secondary scaffold 
functions, however.  For example, derivatives of hyaluronic acid have even been 
successfully used as the primary scaffolding material for adipose precursor cells [20]. 
Collagen is another ECM component that has been used for creating scaffolds.  
Collagen has a number of adhesion domains that provide a surface for cell attachment.  
Because collagen promotes blood coagulation, it has been used as a scaffold for epithelial 
cells, such as fibroblasts and keratinocytes [70].  Furthermore, this scaffold material has 
been shown to allow rat hepatocytes to function.  While a bioactive and biocompatible 
material, collagen has numerous forms that lead to high variability.  Also, a natural 
component, it has a high degradation rate.  
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2.4.2 Other Natural Polymer Scaffolds 
Other natural materials have been used to create scaffolding for cells, each with 
its own set of advantages and problems.  Gelatin, which is derived from collagen, has 
served as a natural scaffold material.  To form gelatin, collagen is denatured into single 
polypeptide chains.  This material is water-soluble, and forms into a hydrogel through 
temperature changes, which can then be stabilized for use as a scaffold through 
glutaraldehyde cross-linking.  As a hydrogel, gelatin has supported cells in orthopaedic 
applications, such as differentiating adipose-derived stem cells into chondrogenic-
expressing cells [70].  
Alginic acid, also known as alginate, is a viscous, hydrophilic polysaccharide that 
is found in the cell walls of brown algae.  Alginate forms into a hydrogel when exposed 
to divalent ions, such as calcium, allowing it to be used as a scaffold.  While not a native 
molecule in mammals, alginate has been shown to be biocompatible, as it does not 
contain any RGD attachment sites needed for cell adhesion.  Furthermore, the presence of 
hydroxyl groups makes this molecule water-soluble.  Despite the reduced likelihood for 
adhesion, various cells have been shown to successfully bind to and function on alginate 
scaffolds.  For example, endothelial cells have successfully attached to custom alginate 
scaffolds without the need for any additional chemical or surface modifications [7].  In 
another study, rat hepatocytes seeded onto alginate sponges were able to secrete albumin, 
which demonstrates the seeded cells were functioning in the in-vitro scaffold [18].  More 
relevant to the scope of this project, alginate was used with a printer to rapid prototype a 
scaffold [7].  Rather than dispense the alginate, however, Boland et al. dispensed the 
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cross-linker onto a pool of alginate.  This experiment suggests that in addition to seeding 
cells, printers could also be used to build scaffolds. 
  
2.5 Synthetic Scaffolds 
 Synthetic polymers offer a number of advantages over natural scaffolds.  For 
example, most natural polymers offer some functionality desired for the scaffold, but can 
lack other vital characteristics.  Synthetic polymers, on the other hand, can be engineered 
to meet specific mechanical or chemical requirements for the scaffold.  Furthermore, 
most synthetic polymers undergo hydrolytic degradation, resulting in a more predictable 
degradation rate [70].  However, issues with biocompatibility could arise because the 
materials or its degradation products are usually not natural.  Currently, over eleven 
synthetic polymers have been researched for use as scaffolds.  Only the more commonly 
used polymers will be discussed below. 
 
2.5.1 Polyesters 
 Polyesters make up the majority of synthetic polymers used in scaffolds.  Poly(L-
lactic) acid (PLLA), is an example of a polyester.  PLLA is a hydrophilic, crystalline 
polyester that exhibits a high melting point and degradation rate, as well as resistance to 
organic solvents.  Furthermore, PLLA is also hydrophobic, making it appropriate for cell 
adhesion.  To control the degradation rate and mechanical strength, PLLA can be co-
polymerized with poly(glycolic acid).  This copolymer is amorphous, resulting in a lower 
degradation rate and mechanical strength when compared to PLLA [70]; degradation can 
last anywhere from a few weeks to a few years by varying the ratio of PGA and PLLA 
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[52].  Lactic acid, the byproduct of PLLA degradation, is biocompatible, as mammals 
naturally break down this molecule during Kreb’s cycle. 
This degradable polyester has been extensively used in tissue engineering 
research.  One study found that PLLA was able to support chondrocytes [70].  Another 
study found that a PLGA scaffold had a lower inflammatory response than a collagen-
based hydrogel, while also showing higher integration with the host body [48].  PLLA 
has also been successfully engineered into an artificial anterior cruciate ligament [12].  
Upon implantation, this artificial ligament induced relatively little immune reaction, 
while showing signs of vascularization.  Finally, more relevant to this project, a study by 
Giordano et al. demonstrated how a printer could fabricate a PLLA structure [17].  These 
research projects show that PLLA has great potential for future tissue engineering 
applications. 
 
2.5.2 Poly(ethylene glycol) 
 Poly(ethylene glycol) (PEG) is a linear polymer consisting of an ethylene oxide-
repeating unit.  As a hydrophilic molecule, this polymer can swell in aqueous solutions. 
On the other hand, its linear structure results in low mechanical stability [70].  
Furthermore, by itself, PEG is non-degradable.  However, the polymer can easily be 
cross-linked with other, degradable polymers to gain this ideal property.  Another 
property of the polymer is its resistance to protein adsorption [13].  While this property 
may, at first, seem to be a disadvantage, researchers have used PEG to exploit this 
specific feature.  In a study by Sanjana et al., for example, PEG was coated onto a glass 
coverslip to serve as a repulsive background [49].  A collagen-based mixture was then 
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patterned, using an inkjet printer, over the PEG-coated coverslip to serve as an adhesive 
for the cells.  Neuronal cells were then plated onto the entire coverslip.  Because of the 
adhesive/repulsive substrates, the neuronal cells could only attach and migrate according 
to the patterned adhesive substrate. 
 
2.6 Bioreactors and Cell Seeding 
 In a traditional tissue engineering process, once a scaffold is fabricated and the 
cells are ready, the cells need to be seeded onto the scaffold.  This seeding occurs within 
a device called a bioreactor, which maintains an environment ideal for cell proliferation.  
The bioreactor achieves this environment in various ways.  First, the scaffold is first 
exposed to the cells to allow for adhesion.  During this process, bioreactors control 
temperature, gradients, and the size and shape of the scaffold.  Furthermore, these devices 
also allow for the transport of nutrients and waste.  Depending on the type of bioreactor 
used, additional forces could be added to stimulate certain characteristics while the cells 
proliferate.  This stimulation factors heavily into how the cells proliferate, migrate, and 
differentiate.  Therefore, for a traditional tissue engineering workflow, the bioreactor 
must be carefully chosen for the desired tissue characteristics. 
 
2.6.1 Static Culture 
 The simplest type of seeding technique is a static culture.  While this technique is 
not considered a bioreactor, it is worth mentioning for comparison.  This seeding 
technique has been widely used for tissues that require a fibrous or porous material [2].  
In this basic seeding technique, the scaffold is placed in a culture plate and submerged 
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with a cell medium suspension and placed in an incubator.  Depending on the cell type 
being used, this process could take from 24-48 hours to adequately seed cells.  However, 
while this technique is the simplest to implement, it also yields the poorest results.  A 
study comparing three seeding techniques found that static cultures had the worst surface 
and matrix distribution / attachment, and poor metabolic activity.  Furthermore, this 
technique also gave the worst yield [8].  As a result of this low yield, more cells must be 
used to seed an adequate amount of cells. 
 
2.6.2 Spinner Flask Bioreactor 
 The spinner flask is the simplest form of bioreactors.  This type of bioreactor 
utilizes convection to seed and stimulate cells.  To seed cells with this technique, the 
scaffolds are threaded onto rods attached to the flask’s cover.  The flasks are filled with 
the cell suspension, which infiltrates the scaffold once the cover is attached.  A magnetic 
stir bar generates convection in the solution.  This convection results in a turbulent eddies 
around the construct, which is believed to improve nutrient transport and expose surface-
attached cells to shear forces [2].  While intended to generate a homogenous cell 
distribution, the shear stresses are varied, resulting in a non-homogenous distribution.  
Ironically, while intended to maintain a well-mixed system, this dynamic seeding type 
actually performs worse than a static culture [8]. 
 
Figure 2.1   Schematic drawing of a spinner flask bioreactor [8] 
 18 
2.6.3 Rotating-Wall Vessel 
 The rotating-wall vessel has become the most widely used bioreactor design for 
bone, cartilage, and other tissues.  This vessel, originally designed by NASA, is 
comprised of two concentric cylinders.  The outer cylinder, which is linked to a rotor, 
houses the scaffold and cell/medium mixture.  This outer cylinder rotates until the 
centrifugal forces negate gravitational forces.  The inner cylinder, which does not rotate, 
is permeable for gas exchange.  A huge advantage of the rotating-wall vessel is uniform 
tissue growth with no specific orientation; this characteristic is a result of the 
microgravity environment generated by the centrifugal forces.  Furthermore, a rotating-
wall vessel can create an almost uniform laminar flow with a consistent shear.  These 
fluid flow characteristics can facilitate with establishing a homogenous cell distribution 
within the scaffold [2]. 
 
 
Figure 2.2   Example of a NASA-designed rotating-wall vessel [14] 
 
2.6.4 Perfusion Bioreactors 
 Unlike spinner flasks and rotating wall vessels, flow perfusion bioreactors utilize 
no moving parts in the bioreactor chamber.  In a perfusion bioreactor, the enclosed 
 19 
scaffold is exposed to a continuous fluid flow.  Unlike the other bioreactor systems, this 
flow can be distributed between the scaffold, the surrounding environment, or both.  
These characteristics can allow for a controllable flow, which can improve nutrient 
transport.  Furthermore, internal flow can expose the luminal surface to shear forces, 
which can facilitate the migration and differentiation of endothelial cells [2]. 
 
2.6.5 Bioreactor Design Considerations 
 While the three bioreactors mentioned above have been used to culture scaffolds, 
different cell types require different environments.  As a result of this necessity, custom 
bioreactors are often developed to best mimic the native physiological environment.  At a 
minimum, the bioreactor must maintain a temperature of 37ºC, humid atmosphere with a 
5% CO2 composition [2].  During the entire operation, the bioreactor must remain sterile.  
This requires a way to change culture aseptically and easily assemble the system.  In 
order to induce the desired cell differentiation, the bioreactor needs to supply similar 
physiological stimuli to the scaffold.  These stimuli could include any of the following: 
growth factors, pulsatile flow, compressive/tensile/ forces, and torsion [2]. 
 When scaling up a bioreactor, cell distribution becomes a major concern.  The 
bioreactor comparison study demonstrated that a bioreactor’s effectiveness at establishing 
a homogenous cell distribution directly affects how well the cells attach and perform [8].  
As the scaffold size increases, care will need to be taken to ensure that the bioreactor 
design will be able to effectively transport cells and oxygen to all parts of the structure. 
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2.7 Dealing With Limitations of Current TE Techniques 
 While traditional tissue engineering has produced positive results in generating 
tissue, several disadvantages limit its full potential.  First, cell distribution is often not 
uniform.  With traditional seeding, a uniform distribution is necessary to ensure 
homogeneity across the entire construct.  Without this proper uniformity, a part of the 
tissue construct may not differentiate or function correctly because it did not receive a 
specific cell.  On a similar note, while the need for a uniform distribution is important, 
current techniques cannot easily place different cell types into specific locations on the 
scaffold [6].  Spatial distribution is important for proper intercellular communication.  
For example, functions such as wound healing and homeostasis require interactions with 
neighboring cells.  Because current techniques cannot specifically place cells, the adhered 
cells will need to migrate to their proper locations.  The time for these cells to migrate 
can as long as several months, which could eliminate critical patients from receiving vital 
tissues. 
 While the issues listed above are all mainly due to cell seeding techniques, 
scaffolds used in traditional tissue engineering also suffer from limitations.  For example, 
PLA scaffolds have characteristically rigid structures.  While this scaffold would be 
appropriate for tissues like bone, tendons, and ligaments [70, 12], this rigidity would not 
be appropriate for contractile tissues, such as cardiac tissue.  Furthermore, traditional 
scaffold fabrication methods, such as casting and molding, often produce tissues that lack 
vascularization.  Vascularization is a vital characteristic if larger tissues are to be 
constructed [6].  While most researchers are working to resolve these problems to 
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continue using traditional techniques, some researchers are looking towards other 
techniques and technology to bypass these issues. 
 By including the cell depositing process with the scaffold creation process, this 
project aims to move task of cell seeding away from the bioreactor and accomplish the 
task during fabrication.  Seeding the cells during scaffold fabrication should reduce 
problems with cell distribution, as the cells would be placed in its proper location before 
the scaffold is complete.  Because of this, the need for cell migration should be reduced, 
leading to faster culture times.  Although no longer responsible for seeding cells, a 
bioreactor would still be needed with a cell printer.  However, a static culture would no 
longer be appropriate for a printed-cell scaffold, as this method was used to seed cells.  
Spinner-flask, rotating-wall and perfusion bioreactors could still be used to impart 
physical and chemical forces to facilitate with tissue growth. 
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3.0 RAPID PROTOTYPING IN TISSUE ENGINEERING 
 Prior to the advent of computers, designs were visualized by creating scale 
models.  This often was a time consuming process, and only provided a visual 
representation of the design.  The computer somewhat alleviated this problem by 
allowing for quick 3D visualization of a design.  While this satisfied many architects, 
engineers also wanted a way to quickly create a physical model that could simulate or 
fulfill the physical function of their design.  Methods of fabricating models, such as 
casting, molding, and milling, were often slow and required expensive materials.  Rapid 
prototyping provided engineers and architects a relatively cheap and quick way to 
fabricate models for visualization and functional verification. 
 Despite its origins in architectural modeling, rapid prototyping technology has 
begun to provide tissue engineers with a number of potential solutions for problems 
encountered when trying to create larger, more complex tissues.  The most significant 
issue that rapid prototyping tried to resolve was the issue of vascularization.  Nutrients 
needed to reach every part of the growing tissue, otherwise necrosis occured.  To 
accomplish this diffusion, a complex internal vascular network was required.  This 
network can only be achieved by directing tissue growth with the scaffold.  Traditional 
molding techniques could not build complex porous networks because the mold would be 
embedded in the interconnecting network.  Casting techniques, while somewhat able to 
integrate the pores, required a lot of time and material to fabricate the casts.  Rapid 
prototyping systems, on the other hand, built models layer-by-layer.  This difference 
allowed for the complex internal pore network to be easily constructed.  Furthermore, the 
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build-on-demand nature of rapid prototyping provided researchers the potential to easily 
create custom architectures, based on a patient’s own needs. 
 Related to the issue of nutrient supply, optimized tissue growth is a function that 
can be potentially aided by using rapid prototyping techniques.  Traditional tissue 
engineering techniques relied on random placement of cells and cell migration in order to 
generate tissue.  To accomplish this task, a tissue scaffold was usually placed in a 
bioreactor to seed the cells.  While sufficient for seeding single cell-types, this technique 
may not be efficient when trying to engineer multi-cellular tissue, as similar cell types 
usually group together in tissues.  Although tissue has been engineered using this 
technique, researchers could experience difficulty when trying to grow larger tissue.  
With larger constructs, cells may have a harder time diffusing deep within the complex 
network, leading to an improper distribution of cells.  Because rapid prototyping systems 
build a structure layer-by-layer, cells could be strategically integrated into a scaffold as it 
is being fabricated.  This on-demand characteristic could allow for 3D-specific placement 
of cells, reducing the need for cells to migrate to its desired location on a scaffold.  
Depending on the complexity of the RP system, multiple cell-types could be strategically 
placed for optimal tissue growth. 
 Currently in the rapid prototyping market, over sixteen RP systems are available.  
For tissue engineers, however, at least six of these systems have been investigated for use 
with tissue engineering applications.  While all six of these systems utilize a layer-based 
construction model, they implement this 3D construction using different methodologies.  
In this paper, these systems will be classified into two primary categories: 3D dispensing 
systems and particle-bonding systems. 
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3.1 3D Dispensing Systems 
Three-dimensional (3D) dispensing systems are a class of rapid prototyping 
devices that primarily extrude a semisolid material.  Following extrusion, this material 
eventually hardens and binds to the previous layer.  Successive layers are then extruded, 
allowing for the formation of a 3D object.  The ability of the extruded material alone to 
support itself when constructing 3D structures is this system’s primary advantage. 
 
3.1.1 Direct Inkjet Printing 
 Despite its name, direct inkjet printing can be considered more as a melt 
deposition system.  A direct inkjet, available through companies such as 3D Systems, 
dispenses fluid in a discontinuous fashion, much like a traditional inkjet printer.  Because 
the system does not rely on a continuous stream of fluid, multiple nozzles and heads can 
be used.  Unlike standard inkjet printers, however, direct inkjet printers utilize a wax-like 
thermoplastic material as the “ink.”  Therefore, like fused deposition modeling, the 
dispensed material hardens, allowing successive layers to be built on top of itself. 
 This technology has not been extensively utilized in tissue engineering 
applications for a few reasons.  First, material choices were severely limited with direct 
inkjet printers.  The polymers used with 3D Systems’ implementation of the technology, 
for example, have not been tested for biocompatibility.  Second, heat generated by the 
system may be harmful to the cells.  A constant temperature must be maintained to 
maintain the thermoplastic material in a semi-fluidic phase.  Temperatures exceeding 
37ºC could put the cells at risk of dying; to contrast, some direct inkjet waxes have melt 
temperatures exceeding 100ºC [35].  Finally, models built using this technique require 
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support structures, usually made of waxes of different solubility than the main material.  
Because of this characteristic, extra processing is required to eliminate the supports, 
making it not only difficult to create the complex internal structure, but also nearly 
impossible for simultaneous cell-seeding.  Because of these limitations, direct inkjet 
printing has been relegated primarily to creating molds for casting with bioactive 
polymers [45]. 
 
3.1.2 Fused Deposition Modeling (FDM) 
 The most common variation of a melt deposition system is fused deposition 
modeling (FDM).  This technology, commercially available through companies like 
Stratasys, utilizes a continuous flow of material.  In a typical FDM system, a polymer 
monofilament is fed into the extrusion head.  A heater within the head melts this 
monofilament into a viscous semisolid.  The melted thermoplastic is then extruded 
through the head’s nozzle onto the build platform or previously deposited layer.  To 
allow for binding of successive layers to form a solid, the entire build platform is 
enclosed within a heated, temperature-controlled cabinet. 
Due to the continuous flow of the polymer, FDM systems typically operate using 
vector-based operations.  Each consecutive layer, as well as each deposited material, can 
be deposited in a different direction and gap spacing.  By controlling these two factors, a 
complex, honeycomb-like internal structure can be formed.  Furthermore, the ability to 
change the direction of successive layers can strengthen the structure.  The zigzag pattern 
to create a solid layer can act much like a layer of fiber, able to resist forces in only one 
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direction.  By changing the direction of each additional layer, the structure becomes more 
able to resist forces in other directions. 
 
 
Figure 3.1   Schematic diagram of a typical FDM system [72] 
 
A few issues limit this technology’s use in tissue engineering.  First, although the 
system allows for variable pores, it cannot create consistent pores in all three dimensions.  
As material overlaps in consecutive layers, pores in the xy-plane can become partially 
occluded.  Second, while the dispensed polymer alone can achieve material buildup, 
support structures are still required to ensure the integrity of the model [4].  However, 
compared to direct inkjet printers, not as much support material is required.  As a result, a 
complex internal structure is still possible.  This possibility allowed researchers like Zein 
et al. to fabricate poly(caprolactone) scaffolds, which could have been used with hard 
tissue cells, such as osteoblasts [72].  Unfortunately, other desired functions, such as the 
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ability to fabricate soft tissue scaffolds and simultaneous cell integration, are more 
difficult to achieve for a few reasons.  First, solvents are required to free the construct 
from its support.  These solvents are often toxic to cells.  Second, the materials need to be 
pre-processed into a filament, which could make the process of integrating cells difficult.  
In addition, the low water content required to create a filament means that hydrogels, 
which are commonly used to support soft tissue cells, cannot be fabricated using FDM.  
Finally, just like direct inkjet printing, the dispensed material relies on heat to melt the 
material.  Although Zein et al. were able to use a biocompatible material like 
poly(caprolactone), they would not have been able to simultaneously integrate cells using 
the FDM system, as the material had a melt temperature of 60ºC [72]. 
 
3.1.3 3D Bioplotting 
 Recently, researchers have been investigating whether a newly developed form of 
3D dispensing could resolve a couple of issues with the previous 3D dispensing systems 
discussed.  Like the other dispensing systems, a 3D bioplotting system dispenses a 
viscous fluid.  However, unlike the solid platform that is used by these other systems, 3D 
bioplotters dispense into a liquid medium.  This medium, which must match the density 
of the dispensed material, provides a neutral buoyancy effect for the model being 
constructed [45].  As a result of the force reduction on the model, the need for support 
structures is eliminated.  This elimination therefore allows for the construction of a 
variable internal pore network, much more complex than what is achievable by FDM. 
 3D bioplotting also reduces the problem of materials.  Other 3D dispensing 
systems, like FDM or direct inkjet printing, are severely restricted in materials options.  
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FDM systems, for example, cannot process many biodegradable polymers due to its very 
narrow processing window; currently, poly(caprolactone) (PCL) is the only known 
degradable polymer that works with FDM [45].  Because of the nature of 3D  
 
 
Figure 3.2   Schematic drawing of a typical 3D bioplotter [31] 
 
bioplotters, a wide variety of materials, including polymers such as PLGA and PCL, 
thermoset resins, and even cement, have been shown to be compatible with the system.  
For instance, a study by Rücker et al. created a PLGA scaffold with a 3D bioplotter [48].  
In their study, the bioplotted PLGA scaffold elicited a weak immune response and 
showed signs of vascularization after implantation.  Furthermore, because of its aqueous 
build environment, bioactive materials, such as proteins, have also been used with 3D 
bioplotters [45].  For example, in addition to the PLGA scaffold discussed above, Rücker 
et al. used the same 3D bioplotting system to fabricate a scaffold containing collagen, 
chitosan, and hydroxyapatite [48]. 
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3.2 Particle-Bonding Systems 
 As its name implies, this RP technology bonds or fuses selected particles in order 
to form a solid.  Unlike 3D dispensing systems, which dispense the build material onto an 
empty platform, particle bonding systems start with the build material already on the 
build platform.  Although present on the build platform, this material is unprocessed and 
unbound.  A head then passes over the material to bind material in a desired pattern.  
Following completion of the layer, a fresh layer of unbound material is placed over the 
bound material, and the process repeats. 
 This RP technique shares similar advantages with 3D bioplotting.  Like 3D 
bioplotting, the structure is surrounded by a supporting medium.  However, rather than 
using a support material that differs from the build material, particle-bonding systems use 
a single material that serves as both build material and support.  As the structure is built 
in a particle bonding system, the surrounding unbound material continuously supports it.  
Therefore, like 3D bioplotters, structures built with particle bonding systems do not 
require additional support structures.  Also due to the lack of support structures, particle-
bonding systems are capable of creating complex internal structures. 
 Three of the most common particle-bonding systems are defined below.  
However, stereolithography is technically not considered to be a particle-bonding system 
because of the material choice.  Because it shares many of the same fundamentals as a 
traditional particle-bonding system, it will be included in this category.  While all these 
systems share the same advantages described above, they each have their own unique 
advantages and disadvantages as well. 
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3.2.1 Stereolithography 
 Stereolithography (SLA) is a liquid-based system that shares some characteristics 
of a traditional particle-bonding system.  Typical SLA systems, available from companies 
such as 3D Systems, house a photo-curable resin in the build space.  To form a solid, the 
submergible build platform is first raised until only a very thin layer of fluid covers the 
platform.  A mobile mirror then directs a UV laser onto the fluid.  Any fluid exposed to 
this UV laser would undergo photo-polymerization, causing a solid to form.  Upon 
completion of the layer, the elevator drops the structure enough to cover the cured layer 
with a fresh coat of liquid resin, and the process repeats. 
 While this method shares a number of the same advantages as a 3D bioplotter, it 
has a serious disadvantage, especially with respect to tissue engineering applications.  A 
3D bioplotter is compatible with a wide variety of materials, ranging from melts, 
solutions, reactive resins, paste, cements, and biologic materials.  SLA systems, on the 
other hand, are severely limited in material options.  Current SLA devices are currently 
restricted to photo-reactive resins.  Furthermore, the available resins are all toxic. 
Despite these disadvantages, SLA has been used for scaffold production.  In one study by 
Chu et al., a lost-mold process was developed around SLA [29].  In their study, the 
standard, commercial epoxy resin was used.  Rather than fabricate the scaffold directly, 
the SLA system was used to fabricate a negative mold of the intended scaffold design.  
An organic suspension, which consisted of hydroxyapatite and acrylic binders, was then 
cast into the mold and cured.  This solid then underwent pyrolysis and sintering to 
remove the epoxy and acrylate, as well as strengthen the scaffold; the group did note, 
however, that a miniscule amount of binder did remain after the procedure.  After all this 
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post-processing, the group was able to obtain a scaffold with channels as fine as 366-!m, 
very close to the 250-!m lower limit of the UV laser [29].  Subsequent research by the 
group showed that their scaffold had an elastic response similar to coralline 
hydroxyapatite.  Furthermore, in-vivo testing demonstrated that osteogenesis was taking 
place within the scaffold [9].  Although some binder material does remain, Chu et al.’s 
work did demonstrate the possibility of using SLA for bone scaffold research.  
 
 
Figure 3.3   Hydroxyapatite scaffolds built using SLA technology [10] 
 
3.2.2 Selective Laser Sintering 
 Selective Laser Sintering (SLS) is a traditional particle-bonding system that 
utilizes a CO2 laser beam [4].  Unlike SLA systems, SLS systems house a bed of unbound 
powder.  An elevator platform is raised to the top of the powder bed, and a roller ensures 
that a flat layer of powder resides at the top.  To form a solid, a deflected laser beam 
selectively scans over the desired location.  The laser beam causes the powder’s 
temperature to rise to its glass-transition point, causing it to fuse with neighboring 
particles.  Following completion of the layer, the platform descends slightly, the roller 
dispenses a new layer of powder over the completed layer, and the process repeats. 
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SLS technology has its own unique characteristics.  Because the particles are 
fused together, structures created using this method can withstand greater forces than 
other structures.  Many SLS systems also allow the end-user to fine tune the 
microstructure.  By controlling the laser’s exposure density, scan speed, and temperature, 
the quality of sintering can be adjusted.  Because binding is achieved by the use of the 
laser’s energy, additional solvents are not required.  However, this RP method also has a 
few limitations.  Like SLA, SLS systems have limited material options. The minimum 
pore size also depends on the powder’s particle size, which is usually around 50 !m in 
diameter [4].  Because of the high temperatures involved when using the laser, the system 
is restricted mainly to thermally stable polymers.  This high temperature also eliminates 
the possibility of simultaneously depositing cells. 
 
 
Figure 3.4   Schematic diagram of SLS workflow [55] 
 
 Although the system was not capable of depositing cells, SLS was still used in 
tissue engineering research.  Its use, however, was mainly restricted for creating 
scaffolds.  In particular, researchers investigated whether the technology could be used to 
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develop bio-ceramic scaffolds for use in repairing bone defects [55].  In one study, 
hydroxyapatite particles were coated in poly(methylmethacrylate), which served as the 
primary binding particle [33].  Unfortunately, this procedure involved the use of an 
organic solvent, which was undesirable for tissue engineering.  However, it did 
demonstrate that a biomaterial could be successfully integrated into a scaffold created 
using SLS.  Another study eliminated the need for solvents by using a powder blend 
consisting of hydroxyapatite and polyetheretherketone (PEEK).  PEEK was a 
thermostable polymer that exhibited a low amount of cytotoxicity [55].  This study 
demonstrated that SLS, like SLA, could be used in bone tissue engineering applications. 
 
3.2.3 3D Printing 
 Not to be confused with direct inkjet printing, three-dimensional printing (3DP), 
developed in 1989 at the Massachusetts Institute of Technology [4], is a powder-based 
particle-bonding system that involves the use of inkjet heads [45].  Like SLS systems, a 
3D printer utilizes a roller to spread and compact powder over a descending build 
platform to create a thin powder layer.  Typical 3D printers, available from companies 
like Z Corp, use a starch-based powder.  However, instead of using a laser to fuse 
particles together, 3DP employs inkjets to bind particles.  The inkjet cartridges, most 
often taken from commercial desktop printers, are loaded with an aqueous binder 
solution, and then dispense ink over selected areas to bind the powder.  Once a layer has 
been exposed to the binder fluid, the roller spreads another layer of powder, and the 
process repeats. 
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Figure 3.5   Schematic diagram of 3DP workflow [25] 
 
 Of all the particle-binding systems, 3DP offers the most flexibility for materials.  
Looking at the previously mentioned systems, SLA can only use reactive, toxic resins; 
SLS is slightly more flexible, being restricted to thermostable polymers.  3DP, on the 
other hand, can use materials based on starch, sugars, polymers, plaster, metals, and even 
ceramics [45].  A caveat of this flexibility is that these materials must be available in 
powder form.  Like SLS materials, the resolution and porosity of a 3DP-created structure 
is heavily dependent on the powder’s particle size.  On average, a 3DP system is able to 
achieve a 300-!m resolution, with pore sizes in the range of 45-150 !m in diameter [69].  
While this places the porosity achievable with 3DP on the same level as SLS, it falls 
short of the larger 250-1000 !m pores that can be created using 3D dispensing 
technologies, such as FDM [4]. 
3DP does have its own set of problems.  One disadvantage of 3DP is that solvents 
often are used with the system.  Usually, organic, though toxic, solvents serve as the 
binder.  In addition to this disadvantage, extra post-processing is required to strengthen 
the structure after printing, which often also involves toxic substances.  This need for 
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toxic chemicals, however, was not always the case.  In one study, for example, Lam et al. 
were able to develop a starch-based powder that was able to be bound using just distilled 
water [69].  Compared to other organic solvents, distilled water was much more 
biocompatible.  This study served as a perfect example of the flexibility that the RP 
method offered, even with the binder solution. 
 Because of its great flexibility and relative low operating costs, 3DP has been 
extensively used in tissue engineering, especially in scaffold creation.  In the previous 
example, Lam et al. not only developed a more biocompatible powder/binder 
combination, but also successfully created scaffolds using their materials [29].  To further 
the strength of the scaffold while maintaining biocompatibility, the group infiltrated the 
scaffold with a PLLA and PCL copolymer.  The group observed a maximum of 12% 
shrinkage following post-processing, with circular pores causing the greatest reduction.  
Not surprisingly, scaffolds infiltrated with a higher volume of copolymer were shown to 
exhibit more water resistance and stiffness. 
 In addition to using standard 3DP techniques, Tay et al. demonstrated how a 
unique step in their workflow aided scaffold creation.  In their study, PCL and poly(vinyl 
alcohol) (PVA) powders, mixed in various proportions, were used as the powder bed.  
Interestingly enough, PVA, this time in a liquid state, also served as the binder.  In the 
post-processing step, the scaffold was immersed in de-ionized water.  PVA, a water-
soluble particulate, leeched out when immersed in de-ionized water [56].  As a limitation 
of this method, the scaffold needed to be heat-treated at 65ºC in order to ensure that the 
scaffold could maintain integrity when immersed for some time [56].  While the heat 
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treatment made simultaneous cell seeding impossible, this unique process demonstrated a 
novel method of creating the complex pore network needed in scaffolds.   
Kim et al. showed how viable printed scaffolds were with cells [25].  In their 
study, PLGA powder was combined with sodium chloride particles to serve as the 
powder bed.  They fabricated a cylindrical construct with interconnected longitudinal and 
radial channels.  In a technique similar to Tay et al., the salt particles were leeched out 
using distilled water, facilitating the creation of the interconnected channels.  Following 
this salt leeching, the scaffold was then soaked in culture medium, statically seeded with 
hepatocytes, and finally perfused in a bioreactor.  Their tests showed successful 
attachment and migration of the hepatocytes.  Lam, Kim, and Tay’s results demonstrated 
that 3DP technology could be a potentially be adapted for tissue engineering. 
 
 
Figure 3.6   Scaffolds created using 3DP and salt leaching [25] 
 
3.3 Choosing the Most Appropriate RP System 
 Almost all of the systems described above have been used for some application of 
tissue engineering.  In terms of scaffolds, everything but direct inkjet printing could have 
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been used.  However, when considering the future ability to fabricate a biocompatible 
scaffold using the same device, SLA became less appropriate due to the toxic resins used.  
Since cells were going to be dispensed with this system, the dispensing system had to be 
“gentle” to the cells.  Some ideal characteristics to achieve this function included a low 
operating temperature and easy integration of cells with the system.  These requirements 
eliminated FDM because of the processing required for the printing materials, as well as 
the heating element to melt the thermoplastics.  SLS was also eliminated because of its 
high-energy output required to fuse the substrate.  After considering all these 
requirements, only 3DP and 3D bioplotting were left as viable options. 
 While both systems featured a substrate-supported build model, the technology 
behind 3DP was chosen for this project for a few reasons.  First, the department already 
had access to a Z-Corp 3DP system, so it could be used as reference for adding scaffold 
fabrication abilities to the system in the future.  In terms of materials, a 3DP potentially 
worked with a greater set of materials, compared to 3D bioplotting.  3D bioplotters 
required the substrate to match the density of the printed solution.  A 3DP, on the other 
hand, required that the powder bind with the printed solution.  Finally, since the 
surrounding environment consists of air, a 3DP inkjet did not require a complex setup; in 
comparison, a 3D bioplotter could have required the use of a needle and higher pressures 
in order to dispense into the fluidic environment.  Although the system could easily be 
adapted for 3D bioplotting functionality, a 3DP-like approach was chosen for simplicity. 
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4.0 INKJET TECHNOLOGY AND ITS ROLE IN CELL PATTERNING 
 The rise of rapid prototyping has initiated research into using various techniques 
to generate the complex 3D models.  Inkjet technology, currently used in 3D Printing, 
offers a number of advantages in rapid prototyping.  It is widely used due to its low cost 
and high availability.  Furthermore, its simplicity leads to lower production costs.  The 
ability to use virtually any fluid allows for great flexibility in materials selection.   
Because of the abundance of tissue engineering research using this technology, as 
well as the simplicity involved in its use, an inkjet-based system was investigated in this 
project.  Utilizing this technology for scaffold development and cell deposition, however, 
requires further study of the various types of inkjets and their characteristics.  Therefore, 
this chapter will provide an overview of the various forms of inkjet technologies that 
have been considered for tissue engineering applications. 
 
4.1 Continuous Inkjet Technology 
Continuous inkjets are one major classification of inkjet technology that is still 
used today.  This form of ink jetting dateed back to 1878, when Lord Raleigh first 
described the method to break streams into a series of droplets [46].  This technology 
utilizes a high-pressure pump to rapidly propel fluid from a reservoir through a tiny 
orifice, creating a high-velocity, continuous flow of fluid.  A piezoelectric crystal then 
oscillates within the nozzle to create a pressure wave pattern, which disperses the 
continuous stream of fluid into droplets.  To control its direction, the droplets pass 
through an electrode, charging the droplets.  Deflection plates then direct the charged 
droplets either to the print surface or to a collection gutter for recycling.  
 39 
 
 
 While continuous inkjet technology could have allowed for rapid deposits of 
fluid, a couple characteristics of this technology made the system unfeasible for handling 
cells.  The primary problem with continuous inkjets was the constant exposure of the 
fluid to the environment.  This constant fluid flow could have potentially resulted in 
contamination if the print environment was not adequately sterilized.  Another issue with 
the system was potentially low accuracy.  With a continuous inkjet, the placement of the 
droplet relied solely on how well the electromagnetic plates deflected the fluid.  
Performing this deflection would have required a complex hardware setup.  To reach 
micron-level accuracy, even more complex hardware could have been required.  The 
nature of the droplet position could also have been affected by the molecular properties of 
each individual droplet.  Droplets that were charged differently could have reacted in 
different ways to the deflection plates.  Therefore, consistency between droplets would 
have become an issue. 
 
 
 
Figure 4.1   Schematic illustration of binary-deflection continuous ink jet [32] 
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4.2 Drop-on-Demand Inkjets 
The other major classification of inkjet technology is known as drop-on-demand 
(DoD) inkjet technology.  Unlike continuous inkjet technology, which has a constant 
fluid flow into a reservoir until deflected onto the print surface, drop-on-demand inkjets 
dispense drops only when required.  This difference results in fewer complex components 
required to operate.  However, because an individual nozzle can only dispense a single 
drop at a time, many nozzles are required to reach the same rate of fluid flow as a 
continuous inkjet. 
When considering applications in cell depositing, DoD inkjets should be the more 
appropriate choice of technology.  As previously mentioned, continuous inkjets would 
have constantly exposed all the fluid to the print environment.  Because drops in a DoD 
inkjet dispense on demand, only the fluid that comes in contact with the print surface 
would be exposed to the atmosphere.  As a result of this difference, the risk of 
contamination should be significantly reduced.  Furthermore, DoD inkjets should be 
more accurate.  Unlike continuous inkjets, DoD inkjets only dispense fluid directly below 
the nozzle.  This limited range of direction would reduce complexity in achieving high-
resolution patterns, currently as accurate as 350-!m [47].  This accuracy would only be 
limited by how precise the positioning motors could move and how small of a droplet the 
inkjet could form. 
Two types of drop-on-demand inkjet technology are commonly used today.  Both 
dispense fluid by the drop, but perform this task using different methodologies.  A third 
technology, which was used for this project,  operated on a completely different set of 
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principles.  However, due to similar characteristics with the more common forms of 
inkjets, this third form was also classified as an inkjet. 
 
4.2.1 Thermal Inkjets 
The first of these drop-on-demand implementations is a thermal inkjet, not to be 
confused with thermal wax inkjets (dye sublimation).  This system, first commercialized 
by Hewlett Packard in the 1970s, utilizes heat to eject fluid from its head.  Fluid is first 
loaded into a chamber in the inkjet head.  A thin resistor then heats up a small amount of 
the fluid (less than 0.5%) until a gas bubble is formed [5].  This bubble then expands until 
a drop is forced out of the nozzle.  New fluid fills in the chamber, and the process repeats.  
Two main variations of this system currently exist.  One version, called a roof-shooter, 
places the heater element above the orifice.  A side shooter, on the other hand, places the 
orifice along the side, with the heating element along part of the wall [32].  
 
Thermal inkjets have been used to dispense proteins.  A study by Roth et al. used 
a collagen solution with an old Canon thermal inkjet [47].  In their study, a glass 
coverslip was coated with agarose, which functioned as the substrate.  The thermal inkjet 
then printed the collagen in various patterns on the substrate.  Following printing, the 
Figure 4.0   Schematic diagram of (a) roof-shooter and (b) side-shooter thermal inkjets [32] 
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coverslip was placed in a well and seeded with neuronal cells and smooth muscle cells 
and incubated for a number of days.  Initial observations, performed by light microscopy, 
showed a number of unattached cells.  However, by the fifth day of incubation, cells that 
did adhere in the printed pattern began to reach confluency.  Interestingly enough, the 
group noted that higher densities of cells when seeding resulted in a shorter lifespan for 
the attached cells; lower densities, on the other hand, lasted longer, but also took longer 
to reach confluency.  These results demonstrated that ECM components could potentially 
be used with thermal inkjets. 
Thermal inkjets have also been used to deposit a variety of actual cells.  Xu et al. 
attempted to deposit ovary and neuromuscular cells [68].  This study reversed the ink and 
substrate that were used by Roth et al. in the previous study.  In Xu’s study, ovary and 
motoneuron cells were loaded into a standard HP cartridge and inkjet printer, while agar 
and collagen were pre-coated onto a glass coverslip to serve as the substrate.  Following 
printing of the different cells, the coverslip was incubated in culture medium.  Like with 
Roth’s results, many cells were observed to be undifferentiated or dead after one day of 
incubation, but the remaining cells were able to show signs of proliferation after several 
days.  The motoneuron cells, in fact, showed signs of differentiation after only 5 days in 
culture.  Both Roth and Xu’s successes demonstrated that thermal printing was a viable 
option for inkjet-based tissue engineering. 
 
4.2.2 Piezoelectric Inkjets 
Canon and Epson currently use the other major drop-on-demand technology, 
known as piezoelectric (piezo) inkjets.  Unlike thermal inkjets, piezo inkjets do not use 
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heat to dispense droplets.  In a typical piezo print head, one side of the fluid chamber 
contains a diaphragm.  This bendable diaphragm is connected to a piezoelectric ceramic 
[32].  Once the chamber is loaded with fluid, an electric charge is applied to the piezo 
ceramic.  This charge causes the piezo ceramic to change its conformation, resulting in a 
volume decrease inside the fluid-filled chamber.  By decreasing the chamber volume, the 
chamber pressure increases, causing the fluid in the chamber to flow out of the one-way 
nozzle. 
 
 
 
Three variations of this form of drop-on-demand inkjet technology exist; 
however, these varieties operate on the same principle of volumetric changes to dispense 
fluid.  In a bend-mode piezo ink-jet, as shown in Figure 4.2a, the piezo ceramic, 
diaphragm, and fluid chamber are aligned in a laminar fashion.  An electric charge, 
applied parallel to the polarization of the ceramic, causes the material to bend towards the 
chamber.  This action forces the diaphragm inward as well, decreasing the chamber’s 
volume.  A push-mode piezo inkjet (Figure 4.2b) operates in a similar fashion.  However, 
in this variation, the piezo ceramic is in the form of a rod, where one end of the rod is 
attached to the diaphragm.  The applied charge causes the rod to expand, pushing into the 
diaphragm, causing fluid ejection.  Unlike the previous two variations, a shear-mode 
Figure 4.2   Schematic illustration of (a) bend-mode, (b) push-mode, (c) shear-mode piezo inkjet [32] 
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piezo inkjet (Figure 4.2c) contains no diaphragm.  Instead, the piezo ceramic itself forms 
an active wall that comes in contact with the fluid.  Electric fields, this time perpendicular 
to the piezo ceramic’s polarization, cause the material to shear, deforming against the 
chamber [32]. 
Researchers have investigated whether piezoelectric inkjets could be used for 
printing human cells.  Saunders et al. tested human fibroblasts with a single piezo inkjet, 
rather than a commercial inkjet system [51].  Unlike the studies performed by Roth and 
Xu, Saunders did not use any pre-fabricated substrate; instead, the cells were directly 
printed into uncoated well plates.  To analyze the effects of changes to the printing 
process, Saunders also varied some controllable conditions, such as excitation voltage 
and rise time.  A doubling in voltage resulted in cell viability dropping from 98% to 94%.  
The group could not find any statistical significance in changes to the voltage rise time, 
however.  Despite the slight decrease in cell viability, Saunders et al. demonstrated that 
piezo inkjets could be used to safely deposit cells. 
Another study, following earlier research by Sanjana et al. [49], attempted to use a 
custom-designed piezoelectric dispenser with neural cells.  In Gustavsson et al.’s study, 
cells from mouse dorsal root ganglia were fed through a proprietary microdispenser [19].  
This microdispenser, modeled after a push-mode piezoelectric jet, was claimed to 
dispense drops with 6-8 !m of precision.  In addition to testing the inkjet design, the 
study also included variations to platform warming, solution density, and print surface.  
The group observed that patterning on glass cover slips was more difficult than printing 
on plastic culture plates, due to frequent droplet aggregation on the cover slips.  To 
compare the effect of temperature on the cells, the group integrated a 30ºC heater on the 
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platform.  When using the heater, lines printed ended up fairly smooth; non-heated lines, 
on the other hand, appeared ragged, due to spreading of the solution.  When the densities 
of both the neurite solution and a bovine serum albumin (BSA)/laminin solution were 
varied, the group noted that a solution with increased density printed out as a thin line, 
due to an increased viscosity.  Neurite growth was shown to follow the printed pattern at 
this high density.  With lower densities, the lines of printed solution came out thicker due 
to the lower viscosity; neurites in this scenario did not follow the pattern of BSA/laminin.  
Gustavsson et al. successfully demonstrated that a piezo dispenser could not only 
dispense neural cells, but also direct their growth. 
 
4.2.3 Solenoid-based Inkjets 
 Solenoids have been utilized for more industrial inkjet designs.  This form of 
inkjet technology operates in a different fashion than traditional inkjets.  In a solenoid-
based inkjet printer, such as the one utilized in this project, no sudden physical changes 
affect the printer fluid to induce droplet dispensing.  Instead, a constant pressure provides 
the driving force behind fluid flow.  This gradient could be established in different ways.  
For example, ink could be loaded into a syringe-like reservoir and become pressurized by 
physically moving a plunger.  Unlike a piezo print head, the pressure gradient in a 
solenoid-based inkjet is continuously applied throughout the entire ink reservoir.  To 
dispense a drop, a current is quickly pulsed through the solenoid valve.  As the current 
passes through the solenoid, a magnetic field is induced.  A plunger, normally keeping 
the valve closed, moves toward this magnetic field, thus opening the valve.  Once the 
valve is open, the previously established pressure gradient forces fluid to eject out. 
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 These solenoid-based inkjets, available through companies such as The Lee Co., 
offer a couple of advantages over the thermal inkjets.  The main problem with thermal 
inkjets is the relatively high-temperature, although quick, bursts experienced by the 
printer fluid to induce bubble formation.  While no adverse results have yet to surface, it 
is possible that more sensitive cells or proteins could be sensitive to these high 
temperatures.  A solenoid-based printer does not need any heating elements to induce 
droplet formation.  As a result, cells could experience less strain through a solenoid-based 
inkjet.  In addition to better cell compatibility, this characteristic could allow for a wider 
variety of materials to be used with the system, especially thermo-sensitive polymers like 
collagen. 
 Few differences exist between impulse and piezoelectric inkjets, however.  Both 
systems operate on the principle of a pressure gradient in the print chamber to induce 
fluid flow.  Piezo inkjets achieve this pressure by physically decreasing the chamber’s 
dimensions in increase pressure.  The solenoid valve in an impulse inkjet, on the other 
hand, uses electromagnets to open its valve, and an already pressurized fluid environment 
to induce flow.  While the piezoelectric system has the disadvantage of slight temperature 
fluctuations from resistance in the chamber walls, the solenoid system has the 
disadvantage of having to constantly pressurize the fluid reservoir.  Since piezoelectric 
inkjets have already been shown to work with cells, this project attempted to demonstrate 
that a solenoid-based inkjet could also be used to safely print cells for tissue engineering 
applications. 
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4.3 Is a Smaller Droplet Better? 
 Apart from the method of droplet formation, one characteristic that also deserved 
consideration when choosing an inkjet should be the inkjet’s droplet size.  This factor, 
which includes the droplet’s volume among other things, can heavily affect the resolution 
of the device.  When considering typical uses for a printer, such as printing text or 
graphics on paper, a tiny resolution is an ideal feature for accurate representation of the 
element being produced.  However, this feature may not be desirable for an inkjet used 
for this project. 
 When considering how the inkjet in this project would be used, a tiny droplet size 
could possibly be a disadvantageous characteristic, rather than an advantage, for the 
system.  For the system to be efficient as well as effective, a single drop would 
theoretically be dispensed where one would want to place a cell.  For this previous 
statement to be effective, the drop dispensed would have to contain at least one cell.  
However, the chances for a viable cell to attach could increase if more cells were 
dispensed in each drop. 
 In an actual test of the cell printer (explained in the next chapter), a cell 
concentration of 6.2E4 cells/mL was calculated from measurements.  From other tests, 
the printer was calculated to dispense about .290 !L per drop. Using these values and the 
relationship 
! 
c = n /Vd  
where c is the average cell concentration of the solution and 
! 
Vd  is the volume of the drop, 
the average cells per drop, 
! 
n, was calculated to be about 17.98 cells.  Research performed 
by Merrin et al. showed that a Poisson distribution could be used to adequately estimate 
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the number cells found in a single droplet [37].  Therefore, the probability, p, of finding n 
cells per drop could be estimated as 
! 
pn =
nne
"n
n!
 
Rounding down the value of 
! 
n previously calculated, the printer theoretically had a 
7.04E-5 percent probability of having one cell per drop.  Although this probability may 
sound low, the chances for finding more than one cell per drop are significantly higher, as 
shown by the blue graph in Figure 4.3.  
 
 
Figure 4.3   Poisson distributions of various cell per drop averages 
To put this distribution into perspective, two theoretical distributions are also 
considered.  If the droplet is assumed to be a perfect sphere, the actual droplet would 
have a diameter of about 0.821 mm, or 0.032 in.  Assuming the inkjet valve is a perfect 
cylinder, that the cylinder contains the full volume of one drop, and that the cylinder has 
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an inner diameter of 0.03 in., this theoretical valve would have a length of about 0.636 
mm.  Keeping the same length but increasing the inner diameter to 0.04 in, this would 
theoretically increase the droplet volume to about 0.516 !L.  Using the first relationship 
defined above and using this larger droplet volume with the same cell concentration, this 
larger droplet would theoretically contain about 31 cells on average. While the 
probability of finding only one cell per droplet decreases to about 1.07E-10 percent, the 
larger diameter would have an even better chance of dispensing multiple cells per drop, 
as shown by the red curve in Figure 4.3.  Now, if the valve diameter were decreased to 
0.02 in, the droplet volume could drop to about .129 !L, resulting in 7 cells per drop on 
average.  This lower average shifts the Poisson distribution to the left, as shown by the 
green curve in Figure 4.3.  As a result, the probability of finding just one cell per droplet 
increases to about 0.63 percent, but the overall probability of finding more than one cell 
per droplet decreases. 
As shown by the above examples, a larger diameter valve may actually improve 
the performance of a cell-depositing system.  The accuracy of the fluid deposit may not 
be as precise, but to improve the likelihood for cell proliferation.  However, if the system 
were also to be used for fabricating a scaffold, precision would be desired.  In this case, a 
smaller diameter would be preferred.  In such a situation, where both functions are 
desired, at least two different-sized nozzles could be used, in which a larger nozzle would 
be used for cells, and the smaller nozzle would be used for scaffolding material. 
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5.0 DEVELOPING THE CELLULAR INKJET SYSTEM 
 The goal for this research project was to determine whether a commercially 
available, solenoid-based inkjet system could be used as a viable cellular deposition 
system.  Initially, the inkjet system was intended to become the foundation for a custom 
3D rapid prototyping system, similar in concept to the 3DP system developed at MIT.  
One long-term goal for this project would be to add the ability to print scaffolds.  If cell 
viability can be confirmed, then it should also be possible to further develop this system 
into a fully functional scaffold rapid prototyping device with the capability for 
simultaneous seeding of cells.   
 
5.1 Materials and Hardware 
 A few considerations with the materials and hardware needed to be taken into 
account when the system was designed.  First, the materials and hardware used in this 
project needed to be biologically inert.  Furthermore, because biohazardous compounds 
would be used, the hardware and materials needed to be sterilizable, as well as easily 
accessible and operable by an operator wearing protective gear.  Lastly, the hardware 
components needed to be readily available and relatively affordable; the target cost range 
of parts for this system was below $5000. 
 
5.1.1 Hardware 
 A Marsh Unicorn inkjet printer (VideoJet Technologies, Wood Dale, Illinois) was 
used for its several inkjet heads.  These inkjet heads were originally linked with a 
manifold to a single input source.  However, once this manifold was removed, these 
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seven inkjet heads could be filled with separate fluids, which potentially allowed the 
system to serve multiple functions.  For example, one inkjet head could have contained a 
binder solution needed to cross-link the substrate bed; a different head could have also 
deposited cells into strategic locations onto the recently formed solid layer, maximizing 
potential for tissue growth.  With seven total inkjet valves available, the system could 
have fabricated complex constructs.  With respect to tissue engineering concerns, the 
inkjets used in this printer should have been harmless to cells.  These inkjet heads, 
INKX0503450A (The Lee Co., Westbrook, Connecticut), were neither thermal nor 
piezoelectric, but were instead solenoid valves.  These valves provided response times as 
fast as 0.25 ms and low power consumption, which lead to low operating temperatures 
under normal loading conditions. 
 
  
Figure 5.1   Inside the printer, showing the nozzle array and print heads 
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Unlike thermal inkjets, which heated the fluid to eject it, the Lee valves required 
fluid to be already pressurized in order to flow once the valve opened.  To pressurize the 
fluid in this system, pressurized gas was fed into the fluid reservoir.  This gas was not 
used to aerosolize the fluid, as in a continuous inkjet system.  Instead, the gas simply 
provided a pressure gradient to generate flow throughout the inkjet head.  The very first 
iteration of the system utilized an AC-powered compressor to provide compressed air.  
This setup allowed for a somewhat mobile system. As long as an AC source was 
available, the system was usable.  However, very early in the testing, the compressor 
seized.  At this point, other options for pressurizing the system were considered.  While 
another compressor could have provided an easily transportable source of pressurized 
gas, the cost of replacing the equipment would have been quite expensive.  An 
appropriate compressor would have had to output sterile air, since the gas was originally 
intended to contact the fluid.  This requirement would have required the use of an oil-free 
compressor, which were quite expensive.  Furthermore, using another compressor would 
have again presented the risk of mechanical breakdown. 
Because of the potential issues with using compressors, the decision was made to 
switch to compressed gas canisters.  Compared to most compressors, compressed gas 
cylinders were not as portable.  Furthermore, because the gases were compressed to a 
high pressure, great care needed to be taken when handling cylinders.  However, gas 
cylinders offered the highest reliability, since no mechanical parts were needed (apart 
from a regulator).  The reduced portability was also a non-issue, since this system was 
not going to travel outside a clean environment.  Furthermore, because there was no 
mechanics involved, the gas supply possibly contained less aerosolized oil than gas from 
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a compressor.  The cost of a cylinder, depending on the gas used, was usually more 
affordable when compared to a compressor.  For example, at AirGas West, a local gas 
supplier, 100 cu-ft of compressed air costed $5.35.  Assuming an airtight seal, this 
cylinder could have potentially lasted for months. 
Initial testing of the gas-cylinder-powered setup utilized compressed CO2 to 
pressurize the system.  While this worked fine to dispense Milli-Q water to ensure basic 
functionality, CO2 would have been an improper gas to use if cells were going to be used.  
CO2 could have made the media more acidic, killing the cells; furthermore, this gas could 
have reduced the percentage of oxygen available to the cells.  Therefore, compressed air 
(AirGas West, San Luis Obispo, California) was substituted for the CO2 tank.  According 
to official drawings from The Lee Co., the solenoid valves had a maximum operating 
pressure of 10 psi.  The compressed air cylinder was pressurized to around 20,000 psi.  
Therefore, a regulator was added to reduce the output pressure to 10 psi. 
In the modified design, the system allowed the compressed air to directly contact 
the loaded fluid.  While this reduced mechanical complications that could occur with 
moving parts, another problem associated with this fix needed to be resolved.  If the gas 
supply were contaminated, the cells would become at risk for contamination.  To address 
this concern, PharmAssure vent filters (Pall Medical, East Hills, New York) were added 
in between the gas supply and fluid reservoir.  This filter was chosen for a couple of 
reasons.  First, the filter’s inlet and outlet connectors utlized luer-lock connectors.  This 
connector allowed for easy assembly when working in the sterile hood.  The more 
important reason for using this filter was its 0.2-!m hydrophobic membrane, which was 
commonly used in pharmaceutical companies for filtration purposes. 
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Figure 5.2   A sample vent filter is attached to top of syringe screwcap 
 
It is worth noting that, while a 0.2-!m pore size was treated as an industry 
standard, the FDA did not formally designate a standard pore size for filters.  Rather, the 
administration defined a challenge using the organism Brevundimonas (Pseudomonas) 
diminuta.  To qualify as a sterilizing filter, the filter had to retain at least 107 organisms 
per cm
2
 of filter area [60].  Therefore, by using 0.2-!m filters, which passed the 
challenge, most microorganisms that might be present in the gas supply would have been 
prevented from contaminating the cells. 
Additional hardware was required to be able to control the custom hardware via a 
computer.  To provide a modular and scalable hardware environment, equipment from 
National Instruments was chosen.  A NI PXI-7334 motion controller (National 
Instruments, Austin, Texas) in a 6-slot PXI chassis (National Instruments), connected to a 
computer via a PXI-to-PCI card (National Instruments), provided the computer to 
hardware interface.  The I/O ports of the motion controller output a 5V TTL signal.   
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Initially, a simple 5VDC relay was used to switch open the valves.  The TTL signal from 
the motion controller was used as the relay’s switching signal, while a DC Regulated 
Power Supply (Extech Instruments, Waltham, Massachusetts) provided 12VDC of power 
output for the solenoid valve.  This setup, however, proved to be dangerous to the valves.  
While no apparent damage was seen, the external body of the valve became very hot.  
Upon consulting with a Lee Co engineer, it was determined that the valve was being 
overdriven.   
Therefore, to trigger the valve but not risk damaging the hardware, an 
IECX0501350AA spike-and-hold circuit (The Lee Co) replaced the relay circuit.  Like 
the relay, this pre-built circuit provided the solenoid valve with a 12VDC pulse to open 
the valve, but then kept the valve open using a lower hold voltage so as to not overdrive 
it.  Upon substitution with the spike-and-hold circuit, a difference in operating 
temperature was immediately noticed; the exterior wall of the valve was no longer 
burning to the touch.  To quantify the operating temperature, a thermocouple, attached to 
a multimeter, contacted the exterior wall of the valve and temperatures were recorded 
every minute as the valve repeatedly dispensed with a 32ms pulse train.  With this circuit, 
external body temperatures did not exceed beyond 23ºC, even with repeated, long periods 
of holding the circuit open.  While this temperature was too cold for ideal cell living 
conditions, it was not too hot to denature proteins. 
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Figure 5.3   Spike and hold circuit with power and inkjet wires connected 
 
 
Figure 5.4   Chart plotting detected solenoid temperatures during repetitive dispensing 
 
Building upon the original goal of developing a rapid prototyping system with the 
inkjet, some motion hardware was modified to be used with National Instruments 
equipment.  Two stepper motors, Zeta 57-51 (Compumotor, Rohnert Park, California), 
and beds provided a two-dimensional platform.  In order to control this 2D bed, the 
motors were wired to a MID-7602 stepper power drive (National Instruments) to provide 
power to the motors.  The purpose of this hardware was to allow for automated, 
positioned fluid deposition.  The 2D bed would have provided XY positioning for 
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fabrication of the current layer.  A third motor would have provided Z-axis motion to 
raise or lower the build platform.  While the 2D bed was wired for use with the motion 
controller and was already functional, the cell viability tests did not utilize any motion to 
minimize potential sources for contamination.  Future projects, however, could utilize the 
hardware to experiment with cell patterning. 
Based off the expenses for this project, the cell depositor was relatively cheap 
compared to a commercial rapid prototyping system.  The suggested retail price for the 
least expensive ZCorp 3D Printer was about $19,000.  In contrast, most of the 
components used in this project could have been obtained for under $10,000 total (see 
Appendix G).  With institutional discounts, however, the cost to purchase the majority of 
the hardware was reduced to the $6000 range.  The most expensive components, by far, 
were from National Instruments.  However, this sub- $6000 cost even included the cost of 
the stepper power drive, which was not used.  Although the inkjet valves were provided 
at no cost, the hardware expense calculation included the cost of seven valves and spike-
and-hold circuits. 
 
5.1.2 Materials 
 Nalgene 180 PVC tubing (Thermo Fischer Scientific, Rochester, New York), 
which resisted many chemicals and was biocompatible, was chosen to link the 
compressed air supply to the syringe inlet.  This tubing was also used to create a luer-lock 
interface at the outlet of the syringe.  To make everything easy to assemble, as well as 
allow for use of the sterilizing filters, luer-lock adapters (Value Plastics Inc., Fort Collins, 
Colorado) were fitted onto the tubing ends.  A 50 mL polypropylene screw-cap reservoir 
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(AutoMate Scientific, Berkeley, California) served as the inkjet fluid reservoir.  Because 
the reservoir and its assembly parts also came in contact with cells, they needed to be 
autoclavable in order to be safely placed in the laminar flow hood.  The rest of the tubing, 
while also autoclavable, did not need to be autoclaved, as it would have been exposed to 
the environment after assembly and was sterilized in some fashion.  For example, the 
tubing between the gas supply and reservoir had a vent filter at the reservoir end to 
sterilize the air that contacts the cells. 
On the other end, the tubing that went from the reservoir to the inkjet inlet was 
sterilized using a 2.5% diluted glutaraldehyde solution (Sigma-Aldrich, St. Louis, 
Missouri) prior to use.  Glutaraldehyde was chosen for a couple of reasons.  First, it was  
 
 
Figure 5.5   Nalgene tubing with pinch clamp and luer-locks on syringe tip 
 
readily available in the lab where the inkjet system resided.  Second, glutaraldehyde was 
non-corrosive to a variety of materials, including rubber and plastics used in this project.  
On the other hand, glutaraldehyde presented some minor health risks to humans.  Short-
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term exposure to this chemical was shown to cause some respiratory and skin irritation; 
long-term exposure, however, could have lead to skin sensitization or asthma [58].  
Furthermore, glutaraldehyde was also toxic to water organisms.  Therefore, this chemical 
needed to be handled in the laminar flow hood with protective gear to minimize any 
exposure and had to be carefully disposed of to not harm the environment. 
A simple cabinet was built to minimize exposure of the inkjet head to the 
environment.  The design was comprised of a five-sided enclosure with a stretchable 
material covering the last side. The inkjet head was integrated with the stretchable 
material.  This design characteristic would allow the cabinet to move while keeping the 
inkjet head in a stationary position above the cabinet’s floor.  With this style, the cabinet 
would have to be mounted atop a 2D stage to allow computer-controlled positioning to 
take place.  0.220-inch-thick acrylic was used to construct the five walls.  Plexiglas, an 
inert material, would allow for easy viewing as the system is in operation.  Furthermore, 
it is much more robust than glass.  However, this material could graze with prolonged 
exposure to solvents.  Since alcohol would be used in the protocol to wipe down the 
cabinet, future revisions should use glass or a solvent-resistant plastic.  For the 
stretchable cover, latex sheets (Small Parts Inc, Miramar, Florida) were used.  This 
material was chosen for its low cost.  However, like acrylic, it is sensitive to solvents like 
alcohol.  Buna-N, also known as nitrile, would be a more appropriate material, as it is 
solvent resistant.  An attempt was made to use this material, but the chosen sheet was too 
thick to be elastic. 
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5.1.3 Software 
 From the project’s conception, LabView (National Instruments) was chosen as the 
software development platform for the system.  The integration between NI’s hardware 
and LabView, as well as the user-friendly graphical programming interface, made 
LabView an easy choice.  In order to control the digital I/O of the motion controller (as 
well as the 2D bed), the NI-Motion library was installed with LabView. 
 A simple virtual instrument (VI), called Cleaning.vi, was created to control 
sterilization of the internal inkjet components that cannot be autoclaved.  The VI was 
designed to run over a ten-hour duration, in which glutaraldehyde was slowly dispensed 
through the printer.  Every 30 seconds, a quick 15 ms voltage spike caused the solenoid 
to dispense a drop of glutaraldehyde.  In addition, every five minutes, ten 15ms pulses, 
which were intended to help dislodge any dead cells or organisms, took place.  This 
pattern of increasing volume continued over the course of a half-hour; every ten minutes, 
50 10ms pulses took place, and every 20 minutes, 100 15 ms spikes took place. 
 
Figure 5.6   Cleaning.vi with 10-minute case shown at bottom 
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Finally, after every half-hour, a full, one-second spike replaced the contact area 
with fresh glutaraldehyde.  After ten hours, the VI automatically paused its execution.  
Following the sterilization, it was necessary to purge the system of any remaining 
glutaraldehyde, as it harmed any cells it came in contact with.  Therefore, the operator 
had to manually activate a glutaraldehyde purge function of the VI, which repeatedly 
dispensed the remaining fluid until stopped by the operator.  After the glutaraldehyde 
purge, an optional media purge was available.  This function was added to ensure that no 
glutaraldehyde remained in the system.  If activated, this function flushed the system with 
media that was loaded by the user following the glutaraldehyde purge. 
 
 
Figure 5.7  Cell printer test VI with default values set 
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Figure 5.8   Block diagram of the cell printer test VI 
 
A separate VI was created for running cell viability tests.  While relatively simple, 
this VI provided some control over the depositing process.  A control was added to 
change the open-valve duration.  Furthermore, an additional control was added to specify 
the duration of the closed-valve state.  By default, the open and closed states had the 
same 10ms duration.  The ability to specify how many times to dispense fluid was also 
included; by default, the VI only dispensed fluid once.  If this value was greater than ’1’, 
then the VI waited to dispense the next drop using the closed-valve duration. 
 
5.2 Testing for Viability 
 Before any future work can be carried on with the system’s development, the 
system needed to be shown to safely print cells.  As a result, cell viability needed to be 
assessed in this project.  While not intended to provide a thorough test of the system, this 
initial viability test had to demonstrate that at least one living cell could be safely 
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dispensed by the system with the designed protocols.  If successful, this test would have 
provided proof-of-concept evidence in support of the solenoid-based inkjets. 
 
5.2.1 Cell-specific Resources and Caveats 
 For this specific viability test, NIH 3T3-L1 mouse fibroblasts were used in the 
system.  This cell type was fairly robust and reached confluence in a short amount of 
time.  Additionally, the materials needed to sustain the cell type were relatively common.  
For example, a complete medium needed for this cell type could have consisted, at a 
minimum, of 10% fetal bovine serum (Sigma-Aldrich) in Dubeco’s Modified Eagles 
Medium.  To minimize the risk of contamination in the medium, 1% of 
penicillin/streptomycin and Fungizone was added to the medium.  While the quick 
growth rate of this cell type was advantageous, confluence needed to be carefully 
monitored.  If the cells were to reach complete confluence, they would have begun to 
differentiate into adipocytes.  Therefore, the cells were usually passaged at a rate of 1:10 
to increase the time to reach confluence. 
 
5.2.2 Maximizing Sterility 
 Although this system was far from usable, sterility was an issue that needed to be 
addressed.  The ultimate goal for this system was to create a fully-seeded scaffold.  If this 
system was ever to be used to actually create implantable tissues, then it had to meet 
FDA requirements for sterility.  These requirements were put in place to maximize 
patient safety when receiving implants.  Therefore, an attempt was made to build sterility 
into the system. 
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 A number of researchers used various techniques to clean their inkjet systems.  In 
a study by Pardo et al., inkjet cartridges were thoroughly rinsed in deionized water up to 
100 times, then alternatively rinsed in ethanol and water [44] before being loaded with 
the “ink.”  With this technique, the group was able to successfully print self-assembling 
monolayers onto gold substrates.  This technique was also adopted by Roth et al. to print 
smooth muscle cells onto a coated, glass coverslip [47].  Boland et al. used a similar 
technique with the inkjet cartridges they used, except they only rinsed the cartridge 
several times [7].  However, in addition to rinsing the cartridge, the group placed their 
entire printer assembly and cartridge in a laminar flow hood and UV irradiated overnight.  
With this technique, Boland et al. were able to successfully print a scaffold and 
simultaneously dispense cells onto the scaffold. 
 A number of steps needed to be taken to ensure the system would be as sterile as 
possible.  First, any components outside the inkjet enclosure that came in direct contact 
with the cells without passing through a filter needed to be fully sterilized.  Therefore, the 
syringe reservoir, adapters, and tubing linking the reservoir to the inkjet inlet were 
autoclaved; these parts remained sealed in its sterile pouch until the cells were ready to be 
loaded.  Once the cells were ready, the reservoir was assembled inside the laminar flow 
hood, following aseptic procedure.  The reservoir remained in the laminar flow hood until 
the bottom port was pinched shut, the solution loaded, and the reservoir capped and 
topped with the vent filter.  By following this procedure, contamination to the internal 
portion of the reservoir was kept to a minimum as the fully assembled reservoir was 
removed from the laminar flow hood. 
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Figure 5.9   An assembled reservoir in laminar flow hood, filled with 2.5% glutaraldehyde 
  
A protocol, sufficient enough to maximize sterility for this half of the system, was 
more challenging to create.  The main problem was with the printer heads.  These valves 
could not be simply autoclaved, as it had electronic components and other wetted 
materials that were not suitable in high temperatures.  Placing the entire system in a flow 
hood was considered; its sheer size, however, made this an unlikely option.  Furthermore, 
should the 2D stage be integrated with the system, concerns with contaminants from the 
stages’ lubrication made the entire system unfeasible for the shared hood.  Therefore, the 
issue of maximizing sterility with the inkjet system was tackled by separating the 
environment from the internal system. 
The strategy to maximize sterility of the internal system involved purging the 
fluid path with a fluid.  In this strategy, any components after the reservoir that came in 
contact with the cell solution was cleaned using a known sterilant.  For this experiment, a 
diluted glutaraldehyde solution was the sterilant of choice.  As mentioned earlier, the 
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cleaning VI was programmed to dispense this sterilant over the course of ten hours.  This 
duration was chosen because it was the average contact time for similar glutaraldehyde 
solutions cleared for use as sterilants by the FDA [59].  Ideally, this solution would 
suffice if the internal components remained completely isolated.  However, the system 
could become at risk upon changing of the fluid reservoirs, as the internal tubing would 
become exposed upon disengagement of the luer locks.  An additional filter was 
considered but not used because the opening of the filter would have also been exposed 
upon disengagement.  Therefore, to minimize this risk, any reservoir-swapping procedure 
in the protocols was quickly performed to limit the time the tubing was exposed.  An 
alternate solution could have been to connect the tubing in the laminar flow hood, though 
this method would have required extra precautions to ensure the tubing was sterile.  
Furthermore, since the connecting components had to be external to the flow hood, the 
risk of contamination at the connection point still remained.  As a result, this alternative 
was not implemented. 
 
5.2.3 Testing Methodology 
 The goal for this thesis was to develop an inkjet system that can successfully 
dispense living cells onto a substrate.  While other commercial inkjet technologies and 
systems have been successfully used in previous research projects, the inkjet system 
utilized in this project was untested for use in tissue engineering applications.  Therefore, 
the inkjet heads and protocols developed for this custom system needed to be tested to 
evaluate its potential.  The highest priority for any cell-capable printing system was to 
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demonstrate cell viability during and immediately after printing [40].  Therefore, before 
any work can continue to further develop this system, cell viability had to be ascertained. 
 In order to obtain cells for testing, a trial run with cells was performed with the 
inkjet system.  A day before the trial, three disassembled reservoirs were autoclaved 
according to protocol (see Appendix B).  One reservoir was filled and loaded with 2.5% 
glutaraldehyde (see Appendices B & C) while the printing chamber was cleaned, then the 
cleaning VI was allowed to run overnight (see Appendix F).  After purging the remaining 
glutaraldehyde, the second reservoir was filled with sterile media, loaded into, and 
purged through the system to ensure all traces of glutaraldehyde were removed.  Finally, 
the third reservoir was prepared for use.  At this time, the cells were removed from the 
incubator and re-suspended with fresh media in the cell laminar flow hood.  The cells 
were then moved to the shared hood and transferred into the reservoir and control 
container, explained below.  This reservoir was then carefully loaded into the system and 
printed into a sterile culture plate for assessment.  
A simple control was also created to compare the inkjet results with.  Before the 
reservoir was loaded with fluid, the fresh cell suspension was divided into two even 
batches.  These batches were randomly assigned to one of two groups.  One group was 
loaded into the reservoir and printed.  The batch assigned to the other group remained in 
the laminar flow hood and was not printed.  Theoretically, the only difference between 
both groups should have been that one group underwent the inkjet process.  In reality, the 
printed cells also were briefly exposed to a non-aseptic environment; however, because 
only the immediate cell viability was being evaluated, this factor was considered 
negligible. 
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Figure 5.10   Inkjet system during purging with 2.5% glutaraldehyde 
 
 To evaluate cell viability, a trypan blue exclusion assay was performed on the 
cells (see Appendix E).  To perform this assay, a cell suspension was created by first 
trypsinizing then centrifuging cells into a pellet, then re-suspending in phosphate buffer 
solution (Sigma-Aldrich).  This suspension was then mixed with 0.4% trypan blue 
(Sigma-Aldrich), and about 10 !L of the mixture was placed into a hemocytometer 
(INCYTO, South Korea).  Normally, cells are colorless in appearance.  Trypan blue, 
which is a staining dye, cannot penetrate the outer membrane of cells; because of this 
fact, viable cells will continue to appear colorless when exposed to trypan blue.  Non-
viable cells, however, will stain blue, as the dye is able to penetrate the membrane and 
stain the cytoplasm.  Under the hemocytometer, both viable and non-viable cells can then 
be counted to determine the percent viability. 
 69 
 The trypan blue exclusion assay was performed twice to evaluate the effect of the 
printing process on the two blocks.  First, immediately after assigning the two batches to 
their group, a 50-!L sample of cell solution from each batch was taken.  The sample from 
each batch went through the trypan blue assay to obtain a cell viability count, which 
served as a baseline measurement.  Another assay was performed on both groups 
immediately after the print group underwent the printing process. 
 
5.3 Issues Encountered 
 Initial test-runs of the system revealed a number of technical issues, which was 
expected from an untested design.  The first issues encountered were related to the 
cleaning process.  In the first trial of the cleaning process, the glutaraldehyde was loaded 
properly into the system and set to dispense overnight using the cleaning VI; after the 10-
hour process completed, however, it was observed that only 5-7 mL of the 50 mL 
actually dispensed.  Inspection of the system revealed that at some point during the 
process, all available air pressure was lost.  The cause for the pressure loss was believed 
to be a minimally opened gas cylinder that was supplying gas too slowly.  Despite this 
irregularity, the internals of the inkjet system did still receive the 10-hour contact time.  
This issue was resolved by simply opening the valve more to provide enough airflow to 
counter any leaks.  Once pressure was restored to the system, the glutaraldehyde was 
purged, and media was flushed through the system following the protocol. 
 Ironically, once the low dispensing problem was resolved, a subsequent test of the 
cleaning VI with a full 50 mL of glutaraldehyde then resulted in a completely empty 
reservoir after the ten-hour runtime.  Evaluation of the code revealed that the one-second 
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drop intervals alone resulted in 150 mL of fluid being dispensed, based on a measured 
flow rate of .290 !L/ms from the nozzle.  Therefore, in order to have a surplus of 
glutaraldehyde remaining to ensure a complete ten-hour contact-time, the cleaning VI 
was modified, removing the one-second interval, which left the 30-second interval as the 
shortest interval.  This revised cleaning algorithm should have resulted in a fluid surplus 
between 20-30 mL if the syringe was filled to 50 mL.  A subsequent run after making the 
change resulted in a 25 mL surplus, which suggested the algorithm’s performance was 
now correct. 
 An issue with the trypan blue test required changes to the protocol.  A cell 
suspension, this time known to be near confluent, was printed through the system.  The 
original recipe for the trypan blue exclusion test called for 1mL of PBS to re-suspend a 
centrifuged cell pellet from 1mL of suspension, and 10 !L of trypan blue.  An alternative 
recipe, which consisted of 200 !L of cell suspension, 300 !L of PBS, and 500 !L of 
trypan blue, was also tested.  However, upon examining the samples from either recipe in 
a hemocytometer, a “grainy” pattern was observed.  Rather than seeing cells either 
transparent or filled with blue, the entire hemocytometer showed what seemed to be 
grains of trypan blue.  It was not clear which cells were viable and non-viable.  Re-
examining all the supplies used, the root cause of the problem was found to be the media 
used.  The DMEM used in the trial already contained FBS.  Research about trypan blue 
indicated that the staining molecule attaches to serum proteins.  Therefore, instead of 
entering non-viable cells, the trypan blue was instead binding with proteins in the 
FBS/DMEM culture medium, resulting in the grainy blue slide.  It was also believed that 
the PBS used was of a 10X concentration, which could have caused osmotic lysis.  To 
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resolve this issue, a simpler trypan blue recipe was used, which consisted of 50 !L of 
resuspended cells and 50 !L of trypan blue.  To re-suspend the centrifuged cells this 
time, serum-free DMEM-F12 media was used.  These changes resulted in usable 
hemocytometer slides. 
 
 
Figure 5.11   Light microscope showing viable cells in a printed solution 
 
 A problem that involved some of the luer-lock surfaced repeatedly during the 
printing process.  Following any printing or purging, the connection between the syringe 
and inlet tubing of the inkjet head often became stuck.  Efforts to loosen the luer-locks by 
hand often failed, sometimes requiring pliers to apply extra torque.  It was first believed 
that the glutaraldehyde was possibly bonding the two luer-locks together.  Glutaraldehyde 
was known to be non-corrosive to metals, rubbers, and plastics, but was also known to 
leave behind a sticky residue.  To test this sticky hypothesis, a tightened luer lock was 
submerged in 2.5% glutaraldehyde overnight.  The following morning, attempts to loosen 
the lock by hand failed.  To work around this issue, the luer-locks were no longer secured 
tightly; instead, the locks were screwed until they barely formed a seal.  Although this 
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workaround may have temporarily worked, this issue might also have shared similar 
causes with the final issue, described below. 
 The most limiting issue experienced thus far was the printer nozzle becoming 
clogged.  After a number of prints with the system, the nozzle became clogged.  The 
source of the clog was located at the exit nozzle of the printer assembly.  An attempt to 
unclog the nozzle by increasing air pressure failed after the syringe outlet tubing burst 
free from the syringe.  This result raised the issue of tubing security, especially since 
electronic components were being used around the system.  To continue operation of the 
system, a temporary workaround, which consisted of rerouting the solenoid outlet tubing 
to an unused, unclogged nozzle, was enacted.  While this temporarily resolved the issue, 
the cause was not known at the time of occurrence.  It was later realized that the media 
purge process was most likely the reason for the clog.  The culture media contained 
nutrients important in cell reproduction.  Part of this milieu consisted of amino acids, 
which were vital for protein synthesis.  Since glutaraldehyde is a fixative, any leftover 
sterilant would have polymerized these amino acids upon contact, which would have 
formed into a gelatinous solid.  As subsequent sterilizations occurred, more of the solid 
probably formed and aggregated until the printer nozzle eventually clogged.  Therefore, 
in order to resolve this issue, the protocol would have to be modified to utilize an inert 
fluid, like saline, rather than culture media.  Furthermore, this saline flush should be 
performed over a long time period, as glutaraldehyde was known to persist through 
flushes longer than originally expected. 
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5.4 Results 
 The initial test with cells only tested for signs of cell viability.  The printing 
procedure was performed as outlined in section 5.2.3.  For each block, a single sample of 
cell solution was taken.  As shown in Figure 5.12, a 96.8% cell viability was observed 
from the single sample taken after printing. 
 
 
Figure 5.12  Calculated data from print vs. control group 
 
5.5 Discussion of Results 
 The print results gave somewhat promising data.  This data showed that some 
printed cells could survive the printing process.  Due to the low sample size and single 
tests performed on each block, however, not much inference can be made between the 
blocks or other research.  However, since the purpose of this project was just to provide a 
proof-of-concept for a possible cell printer design, detailed experimental data was not 
important.  It is possible, however, that subsequent studies, if conducted, could provide 
this statistical comparison with the other cell printing research already published.  With 
the promising result shown above, performing this subsequent work on the system to 
determine its true potential would definitely be justified. 
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6.0 FUTURE WORK AND CONSIDERATIONS 
 
 This project aimed to introduce a system capable of rapid prototyping a scaffold, 
as well as simultaneously seeding cells.  In order to make this task possible, a commercial 
inkjet system was gutted, integrated with LabView hardware, and modified to allow 
multiple materials to be used.  In addition, the framework for 2D motion with stages was 
laid out.  Once functional in LabView, the system was further modified to facilitate for 
the safe integration of cells. 
 While the limits of the system are currently being determined in a separate 
project, initial tests using the system do show potential for the system.  The initial results 
support a need for further study to determine the full potential of the system in its current 
version.  The numerous problems experienced along the way, however, also demonstrate 
that more work is needed to optimize the system. 
 
6.1 What Needs to Be Done 
Although it has been demonstrated that cells can survive the printing process 
through the developed system, more work needs to be performed to improve the system.  
For example, while immediate survival of cells has been demonstrated, a limit needs to 
be determined for the cells during the printing process.  The RP process can be a slow 
and tedious process, often taking hours to complete a model.  In its current state, the cell 
printer is unable to support living cells for more than 20 minutes.  Therefore, the system 
needs to be modified to provide “life support” while the cells wait both in the system and 
on the printed substrate.  This life support system would most likely require a humid, 
temperature-controlled and print environment.  Furthermore, a way to maintain a 5% CO2 
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atmosphere within this environment might be necessary to fully simulate incubator 
conditions. 
Continuing on the topic of limits, the operating limits of the system also need to 
be determined. While some limits, such as maximum operating pressure, are already 
known, the clogged valve experienced during testing demonstrated that the system does 
have a limited capacity for cell population.  A maximum density needs to be determined 
to ensure that the system will not become clogged again.  Protocol changes may also need 
to be implemented.  For example, another purge cycle follow cell printing should be 
considered to ensure that any remaining cells get removed. 
Second, the resolution of the system needs to be drastically improved.  Currently, 
the system is only capable of printing dots in the millimeter range.  Articles discussed in 
this paper mention resolutions in the micron scale.  In order to have any relevance in cell 
depositing, this system needs a significant increase in resolution.  Because the inkjet 
valves used in this project were taken from a system intended to print large text on boxes, 
it is possible that the hardware is not capable of reaching a minute resolution.  Therefore, 
hardware changes might be necessary to improve the resolution.  While smaller volume 
solenoid valves are available from The Lee Co., using piezoelectric inkjet heads is not of 
the question. 
Third, for the system to have any relevance in creating 3D models, two things 
need to be accomplished.  First, some existing hardware would need to be replaced in the 
system.  For example, the motion controllers used in this project are only capable of 2D 
movement.  Therefore, if a third stepper stage were to be added for Z-axis motion, the 
motion controller would need to be replaced.  Position sensing would be another ideal 
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addition into the system.  There is currently no real feedback system to determine where 
the stage is in its vector space.  The system does have home sensors and forward/reverse 
sensors to know when it reaches the home position and maximum travel allowable.  The 
system “guesses” its position by how many steps the motors have turned.  While this 
method would be adequate for generic inkjet applications, a more accurate positioning 
system would be required if the system will be used to dispense cells on the micron scale.  
One method to gain accurate positioning could be to add encoders to the stage setup.  
Encoders have a sensor that read a calibrated scale, and convert that reading into a 
position.  By adding three encoders to each stage and providing the feedback via the 
stepper motor drivers into the VIs, accurate position would be possible if paired with a 
smaller-diameter nozzle.  It should be worth noting that once these hardware changes 
take place, the LabView VIs already created would have to be modified to handle the 
extra dimension and positional feedback. 
In addition to adding better position detection, the overall design needs to be 
modified to allow movement of the inkjet head rather than the build platform.  The need 
for this design change becomes apparent if the system were to be modeled after a 3D 
bioplotter.  The liquid bed would easily become unstable if it were mounted to a 2D 
stage.  Therefore, in order for the system to successfully transform into a 3D rapid 
prototyping system, an overhead 2D-motion stage that can accommodate the inkjet head 
needs to be built.  The Z-axis movement, however, can still raise or lower the build 
platform.  Because of these changes, the chamber design will also need to be modified in 
order to enclose the overhead stage. 
 77 
Finally, although other inkjet systems have dispensed scaffolding material, this 
system has not been tested with such materials.  The solenoid valves could theoretically 
be adapted for either a 3D Printing or 3D plotting setup.  Lam et al. have already shown 
that a 3DP-based system could fabricate biocompatible scaffolds.  Furthermore, Pfister et 
al. have demonstrated that 3D plotters can also be used to fabricate biocompatible 
scaffolds. To fully utilize its potential, the system’s compatibility with scaffolding 
materials needs to be established.  If the system can dispense scaffolding material, such 
as PCL, then it should be possible to create a fully bioactive scaffold from scratch. 
 
6.2 Conclusion 
 With demand for organs outpacing the available supply, tissue engineering has 
attempted to ease this deficit.  The limitations of traditional tissue engineering, however, 
have pushed researchers to investigate other methods of tissue fabrication.  This research 
project has focused on one such tangent of tissue engineering research: tissue rapid 
prototyping.  Various RP technologies investigated by previous studies indicate that most 
of these technologies could be used in some form of TE research. 
 This research project aimed to establish the foundation for a tissue rapid 
prototyping system based on a relatively unused subset of inkjet technology.  The 
findings from this demonstrate that printed cells can survive through the designed cell-
printer system.  Although the long-term survival rates have yet to be determined with this 
setup, the initial positive results indicate that further research with the system should take 
place.  With multiple inkjet heads available and flexibility in the software and hardware 
environment, it should be possible to refine the system into a tool that can fabricate pre-
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seeded tissue engineering constructs, which should be better able to develop into tissues 
when compared to tissues created using traditional methods. 
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APPENDIX A - GLUTARALDEHYDE PREPARATION PROTOCOL 
 
 
A.1 Materials & Equipment 
- 25% Glutaraldehyde (Sigma-Aldrich) 
- Milli-Q water 
- 250 mL media bottle 
- Plunger syringe w/ luer-lock tip 
- 0.2-!m syringe filter 
- Sterile serological pipettes 
- Laminar flow hood 
 
A.2 Safety 
- Perform procedure in laminar flow hood. 
- Do not ingest or allow glutaraldehyde to come in contact with skin! 
- Discard used pipettes and pipette tips in biohazard bin or used pipette tip 
container. 
 
- Wear eye protection gloves, closed-toe shoes and pants during entire procedure. 
 
A.3 Set-Up 
A.3.1 If media bottle is not sterile, autoclave media bottle and cap. 
A.3.2 Spray down work surface of laminar flow hood with IPA or ethanol and 
wipe with Kimwipe. 
 
A.3.3 Spray outer surfaces of all containers and packages, then place in laminar 
flow hood. 
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A.4 Procedure 
A.4.1 Use plastic plunger syringe to take up non-sterile Milli-Q water. 
 
A.4.2 Attach syringe filter to syringe tip, and dispense Milli-Q water into sterile 
media bottle.  Remove syringe tip. 
 
A.4.3 Repeat steps A.4.1 and A.4.2 until 90 mL of sterile water is dispensed.  
Discard syringe and filter. 
 
A.4.4 Using an unused 10mL serological pipette, add 10 mL of 25% 
glutaraldehyde solution to media bottle.  Discard pipette. 
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APPENDIX B - INKJET RESERVOIR ASSEMBLY PROTOCOL 
 
B.1 Materials & Equipment 
- Bottle or vessel containing printer fluid 
- 0.2 micron vent filter (Pall Medical) 
- 50cc syringe with cap (Automate Scientific) 
- 3” length of 1/8” ID PVC tubing (Nalgene) 
- Tubing pinch-clamp 
- Female luer-lock to 1/8” tubing barb adapter 
- Female-luer-lock cap 
- Self-sealing sterilization pouches 
- Sterile serological pipettes 
- Autoclave 
- Laminar flow hood 
 
B.2 Safety 
- Ensure all caps are tightly screwed to ensure no leakage from syringe. 
- Wear eye protection gloves, closed-toe shoes and pants when using hazardous 
chemicals. 
 
 
B.3 Set-Up 
B.3.1 Ensure that all components of assembly are disassembled. 
 
B.3.2 Place tubing, luer-lock components, and pinch clamp in small sterilizing 
pouch and seal. 
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B.3.3 Place syringe and cap (unscrewed from syringe) in large sterilizing pouch 
and seal. 
 
B.3.4 Place pouches into autoclave and use “pouch” setting if available, 
otherwise autoclave for 20 minutes. 
 
B.3.5 Spray down vessel containing printer fluid and autoclaved pouches, and 
place in flow hood. 
 
B.3.6 Wear nitrile gloves and spray down with IPA or ethanol. 
 
 
 
B.4 Procedure 
B.4.1 Open pouches, remove tubing and pinch-clamp, insert tubing through 
openings of pinch-clamp, and pinch tubing shut. 
 
B.4.2 Remove female luer-lock barb adapter from small pouch and insert onto 
either end of tubing. 
 
B.4.3 Remove one male-threaded luer-lock cap from small pouch and tighten 
onto luer-lock. 
 
B.4.4 Remove syringe from large pouch, and insert other end of tubing onto 
bottom nozzle of syringe. 
 
B.4.5 Using a sterile serological pipette, add printer fluid into syringe. 
 
B.4.6 Remove cap from large pouch, and screw cap tightly on syringe. 
 
B.4.7 Remove vent filter from packaging and screw tightly onto syringe cap. 
 
B.4.8 Remove one male-threaded luer-lock cap from small pouch and screw 
onto other end of vent filter. 
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APPENDIX C - INKJET LOADING PROTOCOL 
 
 
C.1 Materials & Equipment 
- Completed syringe reservoir from Appendix B 
- Compressed air cylinder (AirGas West) 
- Regulator w/ 1/8” ID tubing barb adapter 
- 8000-0020, 1/8” ID tubing (Nalgene) 
- MTLL230-1, male luer-lock to 1/8” ID barb adapter (Value Plastics) 
- P-850X, Male luer-lock to 1/16” ID barb adapter (Upchurch Scientific) 
 
- CFT-01-10, 1/16” ID tubing (Small Parts Inc) 
 
- STCR 16/18, syringe tubing reducer (Small Parts Inc) 
- TGY-050-10, 0.050” ID tygon tubing (Small Parts Inc) 
 
C.2 Safety 
- Ensure all caps and adapters are tightly screwed to ensure no leakage occurs. 
- Wear eye protection gloves, closed-toe shoes and pants when using hazardous 
chemicals. 
 
- Ensure regulator and cylinder are shut off and tubing pinched shut when 
disconnecting any tubing. 
 
- Place gas cylinder between yourself and regulator when opening gas supply. 
 
- Do not use equipment if gas connections are leaking. 
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C.3 Set-Up 
C.3.1 Attach one end of tygon tubing to inlet port of inkjet valve, and attach 
smaller diameter nozzle of syringe reducer to other end of tubing. 
 
C.3.2 Attach one end of 1/16” ID tubing to larger nozzle of syringe reducer. 
 
C.3.3 Insert barb of P-850X adapter into other end of 1/16” ID tubing. 
 
C.3.4 Tighten FTLLP-1 cap on P-850X adapter. 
 
C.3.5 Attach regulator to cylinder valve, following manufacturer’s instructions. 
 
C.3.6 Attach one end of 1/8” ID tubing to barb on regulator. 
 
C.3.7 Attach barb of MTLL230-1 to other end of 1/8” ID tubing. 
 
 
 
C.4 Procedure 
C.4.1 Transfer completed reservoir assembly to ink-jet workbench and hold 
vertical using test tube clamp and stand. 
 
C.4.2 QUICKLY remove luer-lock caps from both tubing-side of reservoir 
assembly and from P-850X adapter, then attach luer-locks.  DO NOT 
OVERTIGHTEN LUER-LOCKS! 
 
C.4.3 Remove luer-lock caps from both vent filter and from gas-supply tubing, 
then attach gas-supply tubing to vent filter. 
 
C.4.4 Disengage pinch clamps on reservoir assembly tubing and gas-supply 
tubing. 
 
C.4.5 Ensure regulator screw is loose by rotating screw counterclockwise. 
 
C.4.6 Slowly turn cylinder screw counterclockwise to open cylinder valve, and 
allow regulator pressure to stabilize.  Check for leaks. 
 
C.4.7 Slowly turn regulator screw clockwise until low-pressure gauge reads 10 
PSI. 
 
C.4.8 Power on DC regulated power supply. 
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APPENDIX D - INKJET UNLOADING PROTOCOL 
 
 
D.1 Materials & Equipment 
- Loaded inkjet system from Appendix C 
- Compressed air cylinder (AirGas West) 
- Regulator w/ 1/8” ID tubing barb adapter 
- 382213, Dual DC power supply (Extech) 
- FTLLP-1, female luer-lock cap 
 
D.2 Safety 
- Ensure all caps are tightly screwed to ensure no leakage occurs. 
- Wear eye protection gloves, closed-toe shoes and pants when using hazardous 
chemicals. 
 
- Ensure regulator and cylinder are shut off and tubing pinched shut before 
disconnecting any tubing. 
 
 
D.3 Set-Up 
D.3.1 Use the purge feature in the current LabView VI to remove any remaining 
fluid stored in the reservoir. 
 
D.3.2 Power down the dual power supply before disconnecting any tubing. 
 
 
 
D.4 Procedure 
D.4.1 Turn cylinder screw clockwise to shut off cylinder gas supply. 
 
D.4.2 Turn regulator screw counterclockwise until diaphragm is disengaged. 
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D.4.3 Shut off DC regulated power supply. 
 
D.4.4 Loosen luer-lock between gas tubing and vent filter to bleed off excess air 
in low-pressure side of regulator. 
 
D.4.5 Slowly turn regulator screw clockwise until air barely starts to flow 
through tubing.  Vent remaining air until high-pressure gauge reads 0 PSI. 
 
D.4.6 Use pinch-clamps to clamp gas tubing and syringe outlet tubing shut. 
 
D.4.7 Tighten luer-lock cap onto gas tubing adapter. 
 
D.4.8 QUICKLY disconnect ink-jet inlet tubing from reservoir outlet tubing and 
tighten luer-lock cover onto inkjet inlet tubing adapter. 
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APPENDIX E - TRYPAN BLUE ASSAY PROTOCOL 
 
 
E.1 Materials & Equipment 
- Cell solution 
- 0.4% Trypan Blue solution (Sigma-Aldrich) 
- Serum-free DMEM/Ham’s F12 culture medium (Sigma-Aldrich) 
- 50 mL centrifuge tube 
- 1 mL centrifuge tube 
- Sterile pipette tips 
- 10-1000 !L micropipettes 
- Handheld tally counters 
- DHC-N01, C-Chip disposable hemocytometer (INCYTO) 
- Inverted microscope (Olympus) 
 
E.2 Safety and Notes 
- Perform procedure in laminar flow hood. 
- Do not allow Trypan Blue or cell solution come in contact with skin. 
- Wear eye protection gloves, closed-toe shoes and pants when using hazardous 
chemicals. 
 
- Discard pipettes and pipette tips into biohazard bin or used pipette tip container. 
 
- Count cells within 3-5 minutes of mixing suspension with trypan blue.  Longer 
incubation periods will result in reduced viability counts. 
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E.3 Set-Up 
E.3.1 Spray down work surface of laminar flow hood with IPA or ethanol and 
wipe with Kimwipe. 
 
E.3.2 Spray outer surfaces of all containers, then place in laminar flow hood. 
 
 
 
E.4 Procedure 
E.4.1 Using a sterile pipette tip, transfer 10 mL of cell suspension to centrifuge 
tube.  Discard pipette tip. 
 
E.4.2 Centrifuge suspension at 5X speed for 5 minutes.  Discard supernatant. 
 
E.4.3 Using a sterile pipette tip, transfer 50 !L of serum-free culture medium to 
centrifuge tube and gently mix with pipette to resuspend pellet. 
 
E.4.4 Using a sterile pipette tip, transfer cell suspension to small centrifuge tube. 
 
E.4.5 When ready to count cells, use a sterile pipette tip and transfer 50 !L of 
trypan blue to small centrifuge tube containing suspension.  Pipette up and 
down gently to mix. 
 
E.4.6 At both sides of hemocytometer inlets, use a 10 !L pipette ot add trypan 
blue mixture until area with grid is fully exposed to mixture.  DO NOT 
OVERFILL! 
 
E.4.7 Place hemocytometer on stage of inverted microscope and adjust power to 
100X magnification. 
 
E.4.8 Use handheld counters to count blue cells while also counting non-blue 
cells.  NOTE: Count cells that touch middle line of three-line border at top 
and left sides only; discard cells that touch middle line at bottom and right 
sides. 
 
 
 
 
 
 
 
 
 96 
E.5 Calculations 
 
- cells/mL = (# cells counted / # squares counted) * 10
4
 * (1/5) 
 
- total cells = cells/mL * 0.2 mL 
 
- % viability = (# non-blue cells / total # of cells counted) * 100 
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APPENDIX F - CELL PRINTER TEST PROTOCOL 
 
 
F.1 Materials & Equipment 
- Cell suspension 
- 10 mL Dubeco’s Modified Eagle’s Medium 
- 2.5% glutaraldehyde solution from Appendix A 
- 3 autoclaved, unassembled syringe assembly pouches 
- Culture plate or petri dish 
- Disposable 50 mL centrifuge tube 
- PXI chassis (National Instruments) 
- Dual DC-regulated power supply (Extech) 
- Cell printer system 
 
F.2 Safety and Notes 
- Perform loading procedures in laminar flow hood. 
- Do not allow Trypan Blue or cell solution come in contact with skin. 
- Wear eye protection gloves, closed-toe shoes and pants when using hazardous 
chemicals. 
 
- Discard pipettes and pipette tips into biohazard bin or used pipette tip container. 
 
- Minimize how long cell suspension is away from incubator. 
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F.3 Set-Up 
F.3.1 Prepare 2.5% solution of glutaraldehyde using Appendix A protocol. 
 
F.3.2 Open cabinet door of cell printer and wipe down cabinet surface with 
ethanol or IPA. 
 
F.3.3 Wipe down inkjet nozzles with IPA or ethanol.  Close cabinet door. 
 
F.3.4 Shut down computer. 
 
F.3.5 Power on PXI chassis, ensuring only power light is on. 
 
F.3.6 Power up computer.  Load LabView 7.1. 
 
 
F.4 Procedure 
F.4.1 Open cabinet door, and place beaker beneath inkjet nozzles.  Lower 
printer arm as much as possible to reduce splatter. 
 
F.4.2 Assemble and fill one syringe reservoir with 2.5% glutaraldehyde, 
following Appendix B protocol. 
 
F.4.3 Assemble and fill one syringe reservoir with 5-10 mL of medium, 
following Appendix B protocol. 
 
F.4.4 Load system with glutaraldehyde-filled reservoir, following Appendix C 
protocol. 
 
F.4.5 Place disposable container beneath inkjet nozzles, and close cabinet door. 
 
F.4.6 In LabView, open ‘Cleaning.vi’ 
 
F.4.7 Click on Run button to begin cleaning process. 
 
F.4.8 Once 10-hour cycle completes, click on Purge button to purge any 
remaining glutaraldehyde.  IMPORTANT: Click on the Stop Purge button 
once inkjet dispenses only air at least 6 consecutive times. 
 
F.4.9 Unload used reservoir from system, following Appendix D protocol. 
 
F.4.10 Load system with medium-filled reservoir, following Appendix C 
protocol. 
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F.4.11 In LabView, click on Start Media Purge button to flush system with 
medium.  IMPORTANT: Click on the Stop Media Purge button once 
inkjet dispenses only air at least 6 consecutive times. 
 
F.4.12 Unload used reservoir from system, following Appendix D protocol. 
 
F.4.13 Remove disposable container from cabinet and discard. 
 
F.4.14 Place culture plate/petri dish below inkjet nozzles.  Lower inkjet head if 
necessary, and close cabinet door. 
 
F.4.15 Assemble and fill one syringe reservoir with the cell suspension, following 
Appendix B protocol. 
 
F.4.16 Load cell suspension reservoir into system, following Appendix C 
protocol. 
 
F.4.17 In LabView, open ‘Cell Printer Test.vi’ 
 
F.4.18 Configure number of deposits, “on” duration, and “off” duration to desired 
settings. 
 
F.4.19 Click on the Run button to begin printing cells. 
 
F.4.20 Once print is complete, cover culture plate/petri dish and remove from 
cabinet. 
 
F.4.21 Place disposable container below inkjet nozzles and close cabinet. 
 
F.4.22 In LabView, click on Purge button to purge any excess cell suspension 
from printer.  IMPORTANT: Click on Stop Purge button once inkjet 
dispenses only air at least 6 consecutive times. 
 
F.4.23 Seal, remove, and discard disposable container. 
 
F.4.24 Perform Trypan Blue assay with suspension in culture plate/petri dish, 
following Appendix E protocol. 
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